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INTRODUCTION 
  
Introduction 
Magnitude of the problem 
There has been an exponential progress in the field of neonatology. In 
1963, the son of US President John F. Kennedy died of respiratory distress 
syndrome two days after his premature birth at 34 weeks gestation. 50 years down 
the lane, we are now in a situation where such events are a rarity even in level 2 
care newborn nurseries. The number of surviving preterm babies are increasing. 
These preterm babies contribute to a significant cause of long-term loss of human 
potential amongst survivors. An estimated 150 lakh babies are born too soon 
every year. India ranks first amongst the number of preterm births with 35.19 lakh 
in 2010. (1) 
 
 
Fig 1: Number of preterm births in 2010 in the world  
Intact survival 
Survival of preterm babies is on the rise in India. Current neonatal 
interventions are focused on improving ‘survival’ of neonates. Though every 
attempt is made for ‘intact survival’ i.e. survival without disability, these preterm 
babies are at a substantial risk of future neurodevelopmental delay. Attention to 
long-term outcomes and minimizing disability is essential for optimal well-being.  
The morbidities 
 The major adverse neurodevelopmental outcomes which can be associated 
with preterm birth include cerebral palsy, mental backwardness, blindness and 
deafness. Other than these, they are also at risk of various other minor morbidities 
like subtle tone abnormalities, poor cognitive and language functions, poor 
arithmetic skills, learning disabilities, refractory errors in the eye, hearing 
impairment, behavioural abnormalities, seizures and poor scholastic 
performance.(2-4) Some of these babies have multiple disabilities (5) and some 
of them may persist till school age (6, 7).  
There has been a consistent association between motor functions at 12 
months and cognitive functions at school age (8, 9). This is in consistence with 
Piaget’s theory (Piaget J. The Origins of Intelligence in the Child. London, 
England: Penguin Educational; 1977), according to which the physical motor 
development lays the foundation for future cognitive development. The cognitive 
delays may not be obvious at an early age.  
Factors that influence neurodevelopmental outcomes 
 The neurodevelopmental outcome of a preterm neonate is influenced by 
many antenatal factors, perinatal factors and neonatal factors. Some of the proven 
risk factors are as follows 
Antenatal factors 
 Parent educational status and socioeconomic status 
Previous preterm birth 
Maternal anemia Hb<8 g% 
Maternal malnutrition  
Multiple gestation 
Pre-eclampsia 
Abnormal Doppler 
Perinatal factors 
Risks for early onset sepsis 
Etiology of preterm birth 
Gestational age at birth 
Birth weight 
IUGR / SGA 
5” APGAR < 6 
Acute intrapartum hypoxic events like cord complications and abruption 
Incomplete or no antenatal steroids 
Extramural delivery 
Resuscitated at birth 
Neonatal factors 
Encephalopathy 
Mechanical ventilation 
Acute hypoxic events like air leaks, apnea requiring ventilation 
Shock 
Hypoglycemia 
Sepsis 
Significant Hyperbilirubunemia 
NEC 
BPD 
PDA 
Abnormal neurologic status at discharge 
IVH 
Abnormal neurosonogram 
Growth delay 
The outcome of preterm babies differ among various units. These 
differences are due to varied etiologies of prematurity, intrauterine environments, 
complications that occur during nursery stay, varied management protocols and 
home environment. Although there are various individual well conducted studies 
to prove that all the above mentioned risk factors are associated with poorer 
outcome, there is lack of studies to predict the outcome on a unified basis. Many 
studies that evaluated the demographic, prenatal, perinatal and neonatal 
predictors have failed to devise a method of predicting the outcome. 
Early stimulation 
The recent Cochrane review in 2012 by Spittle et.al. analysed 21 
randomised controlled trials comprising 3133 preterm babies. They concluded 
that early intervention programmes for preterm infants have a positive influence 
on cognitive and motor outcomes during infancy, with the cognitive benefits 
persisting into pre-school age. Cognitive outcomes at 3 years improved by a 
standard mean difference (SMD) of 0.31 standard deviations (SD) in 
developmental quotient (DQ) and at pre-school age, intelligence quotient (IQ) 
improved by a SMD of 0.45 SD. The effect on motor outcomes though small was 
significant, with a SMD of 0.10 SD in motor scale DQ. In spite of the 
heterogeneity between studies due to varied type and intensity of early 
developmental intervention programmes, they have consistently been found to 
modify neurodevelopmental outcome.(10) 
Follow up of preterm babies 
The follow up of preterm babies is not structured / standardized in most 
neonatal units. Stratification of preterm babies based on intra-uterine, perinatal 
and neonatal risks could possibly identify a group of babies at higher risk. Babies 
at lowest risk could be referred back to primary care and require less frequent 
assessment. Given the proven benefits of early stimulation, the risk approach will 
allow optimal utilization of limited, labour intensive, follow up services and 
optimize the early stimulation therapy to those babies at highest risk.  
  
  
 
 
REVIEW OF LITERATURE  
Review of literature 
 In a systematic review in 2012 published in The Lancet, there is ample 
evidence that intrauterine, perinatal and neonatal insults result in significant long-
term neurological morbidity. The overall median risk of developing atleast one 
sequel was 39.4%. The studies included were especially from low and middle 
income countries. Although there is substantial heterogeneity among the included 
studies, it was found that in the analysed decade, the risk of development of 
neurologic sequelae has not changed over time (11). It is of particular interest that 
of the 28212 identified studies, only 153 were suitable for inclusion in the meta-
analysis. Most had poor study methodology. So it is important to do a properly 
conducted study to extrapolate the findings to clinical use.  
 The preterm brain is vulnerable to various insults and they are at a higher 
risk of developing long term neurologic sequelae. Assessing the impact of 
antenatal, perinatal and neonatal factors on neurodevelopmental outcome 
requires a larger sample of preterm babies. This is made possible by neonatal 
networks in developed countries. The Vermont Oxford Network (VON), National 
Institute of Child Health and Human Development (NICHD) neonatal research 
network and the EPICure studies are prominent examples of it.  
 
 
VON network 
In this large multi-centric network study involving 33 centers, 8636 ELBW 
babies who were born from 1998-2003 were included. 6196 babies were 
discharged and among these only 3567 could be evaluated at 18-24 months 
corrected age. Severe disability was seen in 34%. Using multivariate logistic 
regression, the characteristics most highly associated with an increased risk of 
severe disability were cystic periventricular leukomalacia, severe intraventricular 
hemorrhage, 5 min Apgar ≤ 3, severe ROP, BPD, caregiver education <  high 
school, male gender, cardiac compressions during resuscitation at birth, and 
decreasing birth weight. (12) 
NICHD network 
In this large multi-center cohort study by the NICHD neonatal research 
network, 7398 ELBW infants born between 1993 and 1998 were included in the 
study. 4761 survivors were followed up. 3903 infants could be evaluated at 18-
22 months corrected age. Neurodevelopmental impairment was seen in 39.8% 
during 1993-94 which reduced to 27.8% during 1997-98. Logistic regression 
analysis showed that periventricular leukomalacia, BPD, multiple births, male 
gender, postnatal steroids, severe IVH, and poor maternal education were 
associated with poor neurodevelopmental outcome. Of the clinically relevant 
interventions analysed, postnatal steroids and high frequency ventilation were 
associated with increased risk of neurodevelopmental impairment. (13) 
EPICure studies 
In the EPICure study done in UK and Ireland in 1995, 811 infants <26 
weeks of gestation were included. Only 314 babies (39%) survived. Survival 
without disability was 23%. These babies were followed up at 2.5, 6 and 11 years. 
Among these, 283 (92%) were assessed at 2.5 years, 241 (78%) at 6 years. Using 
step-wise logistic regression analysis, prolonged membrane rupture was 
associated with reduced cognition; abnormal neurosonogram and postnatal 
transfer were independently associated with severe motor disability. Nearly half 
had serious disability (14). 
The EPICure 2 study is a prospective National cohort study involving 1031 
surviving preterm infants <27 weeks of gestation born in 2006. 576 infants were 
followed up. This study showed that both the mortality as well as the long term 
neurodevelopmental outcome improved over time. Lower gestational age and 
male sex were associated with poorer neurodevelopmental outcome (15). 
Local neonatal networks 
In a follow up study of 205 VLBW babies in Germany, 142 were 
discharged (69.3%). Severe disability was diagnosed in 36 (25.4%) infants. 
Lower gestational age at birth and severe IVH were associated independently 
with severe disability. Also the difficulty in achieving high follow up rates even 
in a neonatal network is emphasized in that study (16).  
Studies from developing countries 
Neurodevelopmental outcome studies form resource limited settings may 
differ from the studies done in developed countries. Also the demographics of the 
preterm babies may differ probably related to suboptimal antenatal and perinatal 
care. Though there is a lack of well-established neonatal network in these 
countries, there are many well conducted follow up studies from individual 
centers. 
In a single center follow up study of VLBW infants from Johannesburg, 
314 infants were included in the study during 2006-07. 178 babies (56.6%) were 
discharged. 26 lost to follow up and 9 died post discharge. Of the remaining 143, 
Bayley Scale of Infant and Toddler Development Version III (BSID III) was done 
in 106 babies (74%) at a median age of 16.5 months. 23 infants had severe 
neurodevelopmental delay. The risk factors that are independently associated 
with poor outcome are duration of hospital stay, male gender, resuscitation at 
birth, hypothermia and cystic PVL (17). 
In another similar study from a tertiary care hospital in Bangladesh 
published in 2006, 159 infants <33 weeks of gestation were enrolled. 16% died 
and 19% lost to follow up. More surprisingly, they have found a 
neurodevelopmental impairment in nearly two-thirds of infants. Socio-economic 
status assessed by family income and educational status had the most significant 
impact on post discharge mortality (18). 
An unpublished pilot study on 225 preterm babies  <33 weeks from a 
referral teaching NICU of south India has demonstrated that risk stratification 
identified 12.5 % babies as high risk who had had higher disability rates of 18% 
at one-year age (corrected for prematurity) and would benefit most by early 
stimulation. Most babies (87.5 %) had a risk of only 4.5 % (baseline) and could 
be assigned to limited follow up.  
Study justification 
Data from the western world cannot be directly extrapolated to our set up 
as the demographics may differ among population. There are also no well-
established neonatal networks in India. Except for the one unpublished study 
from south India, we could not find any such studies in India. The primary reason 
for such a scenario in India is the lack of structured follow-up programs for 
preterm infants. This is probably the need of the hour in most neonatal care 
centers in India. In addition to standardizing follow up care services, the results 
of such a study will provide an opportunity for introspection and quality 
improvement of care process in the NICU. It also ensures optimal utilization of 
follow up services and maximal early stimulation therapy to those babies at 
highest risk. The infra-structure, manpower and medical management of preterm 
babies would differ from center to center and hence each center validation is 
necessary for the risk stratification tool. 
  
  
 
AIMS AND OBJECTIVES 
 
  
Purpose of the study  
1. Standardization of  follow up and early stimulation program for at-risk 
NICU babies  
2. Assessment of magnitude of neurodevelopmental disability in preterm 
neonates 
3. Association between intra-uterine insults, neonatal morbidities, 
management in NICU and developmental outcomes – an opportunity for 
standardization and quality improvement of care process in NICU  
4. Evolving a tool that can be used in early neonatal period for prediction of 
developmental outcomes. This will be used for anticipatory guidance of 
parents and care givers and optimizing early stimulation and follow up 
services 
Study Hypothesis 
It is possible to make a prediction about an infant’s neurodevelopmental 
outcome using a pre-discharge screening score, compiling intra-uterine and 
neonatal risk characteristics. It would help to optimize early intervention to those 
at higher risk and decrease the number of infants followed up in the lower risk 
group, thereby allowing best use of the limited available follow up resources. 
  
Objectives of the study 
Establishing a risk stratification tool (based on intra-uterine and neonatal 
insults) for predicting major neurodevelopmental disability (cerebral palsy, 
mental retardation, blindness, deafness) at one year (corrected for prematurity) in 
preterm babies (gestation <34 weeks).  
  
  
 
MATERIALS AND METHODS 
  
Setting:  
The newborn units in Institute of Child Health and Hospital for Children 
and Institute of Obstetrics and Gynecology, Egmore. Both are tertiary level 3 care 
NICUs. The units have the necessary infra-structure, resources, man-power and 
protocols to provide optimal care to preterm babies. They have the necessary 
follow up services to provide standardized follow up care to the at-risk graduates. 
Type of study:  
Observational study: Prognostic study 
Study period: 
Enrollment period: 
4 months: September 2012 – January 2013 
Follow up period: 
12 months age corrected for prematurity  
Study protocol 
Definitions of variables, outcomes, protocols for medical management and 
follow up were discussed with the Unit Heads and agreed upon to ensure 
uniformity of clinical management amongst the inborn and outborn Units. The 
NNF clinical practice guidelines are followed for individual case management.  
Follow up team 
The follow-up service has the following team members  
1. Trained Neonatologist and allied medical specialists  
2.  Developmental physician 
Denver Developmental Screening Test  
Developmental assessment scale for indian infants - DASII 
CDC grading for major motor milestones  
Amiel Tison method of assessing tone  
Growth assessment based on WHO growth charts 
3. Ophthalmologist 
ROP screening and therapy 
Refraction assessment 
Squint assessment  
4. Audiologists and ENT surgeon, Speech therapist  
5. Physical Medicine and Rehabilitation team  
  Neurodevelopmental therapy 
  Early intervention techniques 
  Physiotherapy 
  Occupational therapy 
6. Radiologist trained in neurosonography  
7.  Pediatric Neurologist 
 The principal investigator coordinated the follow up services. The 
principal investigator also underwent a training program for performing DASII 
(Developmental assessment scale for Indian infants) at Pune for 1 week.  
The ophthalmologists from the Regional Institute of Ophthalmology (RIO) 
had regular visits to both of our intramural and extramural centers weekly once 
(on Saturdays in intramural center and on Wednesdays in extramural center). 
They performed ROP screening both for outpatients and for inpatients at the 
bedside.  
If an infant required therapy for ROP, they are referred to RIO where 
facilities for laser photocoagulation and surgery for retinal detachment are also 
available. For hospitalized infants requiring therapy, the infants are transported 
in the neonatal 108 services accompanied by a neonatal resident trained in 
neonatal resuscitation. 
  
Subjects:  
• Inclusion criteria 
– All viable (>23 weeks and >400 grams birth weight) preterm babies 
(≤ 34 weeks gestation) admitted to the nursery and discharged after 
completion of neonatal care. 
– Both inborn and outborn babies who were referred in the first 48 
hours of life (as babies referred later will not have accurate records 
of their initial NICU risk factors) 
• Exclusion criteria 
– Babies with  
• major malformation  
• requiring major surgery 
• dysmorphism  
– Intrauterine infections 
– Babies referred out of the NICU to another hospital before 
completion of care 
– No consent from parents 
 
Definition of outcomes 
Primary outcome 
• Death or Major Neurodevelopmental Disability (NDD) at 12 months 
corrected age   
• Major developmental disability is defined as any one the following four: 
– Motor impairment  
• DASII motor score less than 70 at 1 year corrected age  
– Mental impairment 
• DASII mental score less than 70 at 1 year corrected age  
– Visual impairment 
• Blindness - complete loss of vision in one or both eyes   
– Hearing impairment 
• Profound hearing loss warranting assistive devices in one / 
both ears 
Secondary outcome 
• Death or any neurodevelopmental disability (major or minor) at 12 
months corrected age 
• Minor Neurodevelopmental Disability is defined as any one of the 
following four at 12 months corrected age  
• Infants with DASII motor score of 70-85 
• Infants with DASII mental score of 70-85 
• Refractory error / Squint 
• Impaired hearing not requiring assistive devices. 
 
End point in the study for enrolled baby 
Follow up at 12 months age corrected for prematurity / death / discharged 
from NICU before completion of NICU care / lost to follow up. 
 
  
Fig 2: Study flow diagram - protocol 
 
For defining the primary outcome which is dichotomous, they are grouped 
as either death/major delay or minor/no delay.  
  
Risk factors for neurodevelopmental outcomes  
Intra-uterine insults and neonatal morbidities and management related 
issues associated with adverse neurodevelopment have been well described and 
their severity and association with outcomes previously published. The risk 
factors likely to affect neurodevelopment will be recorded from patient records 
on a structured form.  The risk factors are classified according to their severity 
into various risk – categories. 
Risk factors are recorded in a record form as follows 
Baseline data 
Gestational age (in weeks): 
Birth weight (in grams): 
Weight centile : <3rd / 3rd -10th / >10th  
Length centile: <3rd / 3rd -10th / >10th 
Head circumference centile : <3rd / 3rd -10th / >10th 
Antenatal data 
 Fetal well-being: normal / abnormal non-stress test/ biophysical profile <5 
 Risks for sepsis: maternal fever / pPROM / chorioamnionitis 
 Multifetal gestation: singleton / dichorionic / monochorionic twins / triplets / higher 
 Preeclampsia: absent / mild / severe 
 Doppler changes: cerebral redistribution / AREDF / not done 
Perinatal data 
 Acute hypoxic events: abruption / cord prolapse / none 
 Antenatal steroids:  dexamethasone / betamethasone 
    None / partial course / full course 
 Place of delivery: intramural / extramural 
 Resuscitation at birth: none / PPV / intubation / cardiac compressions 
 5” APGAR: <6 / >6 
Neonatal data 
 Duration of ventilation: not ventilated / <3 days / 3-7 days / >7 days 
 Acute hypoxic events: air leaks / hypocarbia / apnea requiring resuscitation 
 Encephalopathy: absent / perinatal depression / HIE 
 Shock: absent / shock with normal BP / hypotensive shock 
 Hypoglycaemia: not present / asymptomatic / symptomatic / with seizures 
 Duration of hypoglycaemia: <3 days / >3 days 
 Sepsis: can’t exclude / culture +ve sepsis / sepsis with hypotension or meningitis 
 Jaundice: none / needs phototherapy / needs exchange transfusion / has BIND 
 NEC: absent / stage 1/ stage 2/ stage 3 
 BPD: absent / mild / moderate / severe 
 PDA: not present / medical closure / surgical closure 
 IVH: not present / mild (grade 1/2) / severe (grade 3/4) 
 Neurosonogram: normal / ventriculomegaly / PVL 
 Neurological status at discharge: normal  /abnormal 
  
Assignment of risk: 
 The risk factors are classified as mild or moderate or severe based on the 
following table.  
Table 1: Risk stratification criteria 
 Mild risk Moderate risk Severe risk 
Gestation  33 -34 weeks 30- 32 weeks < 30 weeks 
Birth weight  >1501 gm 1251 - 1500 gm <1250 gm 
Intra-uterine 
insults   
 Fetal growth 3rd – 10th 
centile  
Abnormal non-stress 
test or biophysical 
profile < 5 
Maternal fever  
pPROM  
Dichorionic twins  
Fetal growth <3rd centile  
Severe maternal pre-
eclampsia (seizures) 
Monochorionic twins / 
triplets or higher order 
Clinical chorioamnionitis  
Cord prolapse  
Abruption placenta  
Absent / reversed end 
diastolic flow 
Antenatal 
steroids (ANS) 
 Incomplete course or < 
24 hours from last dose  
No antenatal steroids 
Need for 
resuscitation at 
birth  
 Need for resuscitation 
(including positive 
pressure ventilation) 
Need for extensive 
resuscitation  (chest 
compressions, 
epinephrine) 
Need for 
ventilation  
 Ventilation with 
normal blood gases and 
no air leaks  
Ventilation abnormal 
blood gases and air leaks  
 
Perfusion   Shock (poor perfusion) 
with normal blood 
pressure  
Shock (poor perfusion) 
with hypotension  
Shock therapy  Saline bolus  Inotropes  Steroids  
Hypoglycemia   Hypoglycemia 
(asymptomatic) 
Symptomatic 
hypoglycemia 
Blood sugars   32 – 46 mg/dl <32 mg/dl 
Days of 
hypoglycemia  
 1-4 days  > 5 days 
IVH   
 
IVH < grade III Grade  III IVH or 
ventriculomegaly, PVL  
Infection  Can’t 
exclude 
sepsis 
Sepsis Sepsis with hypotension / 
Meningitis 
Neonatal 
jaundice 
Requiring 
phototherapy  
Requiring exchange 
transfusion 
Has BIND  
Hypothyroidism   Hypothyroidism  Treatment delayed (not 
normalized by one month) 
  
Variable Definitions  
Period of gestation:  
The following order is taken for accurate assessment of gestational age 
First trimester antenatal ultrasound scan at 6 to 12 weeks  
Second trimester (upto 20 weeks) antenatal ultrasound scan 
LMP based EDD 
The extended new Ballards score  
This will be also be used to estimate gestation if the 
neonatologist feels the baby’s gestation appears different from the 
scan estimate. If the difference is more than 2 weeks, the extended 
New Ballard Score will be used to assign gestation.  
Completed weeks of GA will be used for analysis.  
Birth weight:  
Measured using a 5-gram accuracy electronic weighing machine which is 
calibrated regularly (weekly) 
Resuscitation guidelines at birth  
NRP 2010 guidelines (19). 
  
Ventilation – abnormal blood gases / air leaks  
The duration of ventilation is recorded.  
Acute hypoxic events include 
Air leaks 
Apnea requiring resuscitation 
pCO2 < 35 and > 65 mmHg in first 72 hours 
Hypotension: 
Mean blood pressure measured by non-invasive BP monitor < gestational 
age in weeks in 1st week, and <35 mm Hg after 1st week of life 
Poor perfusion: 
Tachycardia  with altered alertness, poor capillary refill time, cool 
extremities, decreased urinary output (hypotension is a late sign of shock in 
neonates) (20) 
Symptomatic hypoglycemia:  
Blood sugar < 40 mg/dl with neuroglycopenic symptoms like jitteriness, 
seizures, lethargy, apnoea. The capillary blood glucose value must be confirmed 
atleast once with the laboratory value. 
  
Neurosonogram:  
Routine screening cranial ultrasonography is performed on all enrolled 
preterm babies once between 7 and 14 days of age and repeated at 40 weeks' 
postmenstrual age. It’ll be done by the primary care neonatologist and confirmed 
by pediatric radiologist if abnormal. Intraventricular hemorrhage, if present is 
graded and noted. Periventricular leukomalacia and low-pressure 
ventriculomegaly, are included under abnormal neuro-sonogram. There is 
insufficient evidence for routine MRI of all VLBW preterm infants with abnormal 
results of cranial ultrasound(21). Hence it is not done for this study routinely for 
all babies 
Sepsis:  
Presence of at least two clinical symptoms and at least two laboratory signs 
(from the table below) in the presence of or as a result of suspected or proven 
infection (positive culture or microscopy) (22). This is endorsed by the report on 
the expert meeting on pediatric and neonatal sepsis, European medicines agency 
in June 2010. The details of the proposed definitions are attached in annexure 1.  
If the clinical course is strongly suggestive of sepsis, and not fitting with 
the definitions as above, then the baby is categorized under clinical sepsis and if 
only screen is positive, the baby is treated till culture reports and categorized as 
“screen positive”.  
Neonatal jaundice: 
The thresholds for phototherapy or exchange transfusion are from NICE 
protocol (23). Brainstem Evoked Response audiometry (BERA) is done for all 
babies who required exchange transfusion or has features of acute bilirubin 
encephalopathy. BIND scoring is not done as its classically seen only in late 
preterm and term babies. 
Hypothyroidism:  
In accordance with the AAP practice parameter, testing with TSH after 3 
days and within 2 weeks of life (24). Values of TSH more than 20 would be 
investigated with free T4 also.  
Neurodevelopmental screening and Follow-up schedule  
The neurodevelopment screening and follow-up will be coordinated by the 
principal investigator. The neurological examination and interpretation of 
developmental assessment will be done by the principal investigator / pediatric 
neurologist if necessary. Efforts would be made to ensure follow up. Telephone 
numbers of both the parents are recorded.  
Neurodevelopmental follow up is done at 4, 8 and 12 months of corrected 
gestational age. This categorization of age is primarily to facilitate assessment of 
major motor milestones by CDC grading. At every visit, screening is done with 
DDST-2. Tone is assessed by Amiel-Tison method. Growth is assessed using 
WHO growth charts.  
Babies with suspected neurodevelopment / neuro-sensory findings will be 
assessed more frequently and appropriate interventions initiated. Development 
Assessment Scale for Indian Infants (DASII) will be done at 12 months age 
corrected for prematurity. The MoQ (Motor Quotient) and MeQ (Mental 
Quotient) are documented. 
Vision:  
Retinopathy of prematurity (ROP) screen  
Screening for ROP is performed in all enrolled neonates. The first 
retinal examination is performed not later than 4 weeks of age in infants 
born ≥ 28 weeks of gestational age. Infants born < 28 weeks or < 1200 
grams birth weight are screened early, by 2-3 weeks of age, to enable early 
identification of Aggressive posterior ROP (AP-ROP). Findings will be 
recorded as per ICROP (International classification of ROP) (25). 
Refraction and squint 
Babies will be tested between 9-12 months corrected age for squint 
and refractory errors.  
  
Hearing screen:   
Distortion product Oto-acoustic emission (DPOAE) testing is done at 
discharge. Behavioural observation audiometry (BOA) is done within 3 months 
of life. BERA is done if DPOAE or BOA is abnormal. The tests will be carried 
out by audiologists.  
Correcting for prematurity  
The age of developmental follow up will be corrected for prematurity (full 
correction) – age for assessment will be calculated from the expected date of 
delivery (40 weeks). 
Statistical methods 
 In the unpublished pilot study, there are 87.5 % babies at low risk (score 
1,2) and 12.5 % with high risk (score or 3 or more) (1: 7 ratio of controls to cases). 
The proportion of babies with major neurodevelopmental delay (NDD) in low 
risk group was 4.5 % (0.045) and in the high risk group was 18 % (0.18).  We 
will need to study 38 high –risk and 266 low- risk subjects to be able to reject the 
null hypothesis that the major NDD rates for high-risk and low-risk subjects are 
equal with probability (power) 0.8.   The Type I error probability associated with 
this test of this null hypothesis is 0.05. The sample size was calculated using an 
uncorrected chi-squared statistic. 
Univariate analysis was used to compare risk variables and outcome at one 
year. Multiple logistic regressions were employed to find independent 
associations of risk categories with outcomes. Combination of risk factors were 
tested. A weighted risk score was evolved.  
Ethics  
Ethical clearance was obtained from the institutional ethics committee. The 
form is attached in appendix 1. 
Consent 
Permission to use patient data for research was obtained from the 
concerned intramural and extramural centers. The identity of patient was kept 
confidential. Patients refusing enrollment were offered the same follow up and 
early intervention as to enrolled babies.  
  
  
 
OBSERVATION AND RESULTS 
  
Results 
 There were 1639 babies who got admitted to the nursery during the 
enrollment period. Both inborn and outborn babies were included. During that 
enrollment period, 349 (21.3%) babies were preterm ≤34 weeks of gestation. 
Fig 3: Study flow diagram 
+  
 28 babies had major malformations which can affect the 
neurodevelopment. 11 babies got admitted after 48 hours of life; these babies 
were excluded as the initial treatment data may not be available or is not 
standardised. 6 babies were excluded for non-feasibility of follow up. Non-
feasibility of follow up was decided if referral has been from a distance more 
than 200 km from the Institution. After these exclusions, the remaining 304 
babies were enrolled. 
 We had 91 deaths (29.9%) prior to discharge. All the remaining 213 were 
followed up. 29 (13.6%) babies were lost to follow up. Attempts were made to 
ensure maximal follow up through telephonic calls to both the parents or mails, 
which were sent to their corresponding house addresses. In spite of our efforts, 
we were unable to follow these 29 babies.  
During follow up, 9 babies died within 3 months of discharge. All these 9 
babies had growth delay. 5 of them had radiological evidence of pneumonia and 
had worsening respiratory illness prior to death. 2 had culture positive 
septicaemia. The remaining 2 died at home and had respiratory symptoms. The 
cause of death could not be ascertained clearly through telephonic 
conversation. The remaining 175 were followed up to 1 year of corrected age.  
 For defining the primary outcome, DASII, hearing and vision assessment 
were done at one year of corrected age. None of the babies had hearing 
impairment requiring assistive hearing aids or complete blindness. The primary 
outcome is solely reflected by the motor and mental subsets of the 
developmental quotient assessed by DASII. The scenario with secondary 
outcome is also the same. None had hearing impairment. And also none had 
refractory errors requiring correction with glasses and only 2 babies had squint. 
Both these 2 babies had developmental delay as assessed by DASII. So the 
secondary outcome measures are also reflected purely by the outcomes as 
assessed by DASII. 
Baseline distribution 
 The gestational age and birth weight distribution of the enrolled babies are 
depicted below in relation to survival outcome.   
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Fig 4: Gestational age (weeks) distribution and survival
Survived Death Lost follow up
 The survival of extreme preterm babies < 28 weeks of gestation (26.8%) 
or ELBW babies (17.1%) is very low. There were no survivors in ≤27 weeks of 
gestation in our study during the study period.  
 
 
 The birth weight data also suggests that the survival increases with 
increasing birth weight. There were no survivors in the incredibly low birth 
weight group (birth weight < 750 g). 
 There is also a high proportion of SGA babies (23%) in our study 
population. This is comparable with the national average of SGA babies in India. 
This should be taken into consideration before comparing birth weight data with 
other studies. Our population’s lower birth weight infants may have higher 
proportion of higher gestational age infants.  
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Fig 5: Birth weight and survival
Death Survived Lost follow up
   
 
27% of our study population were a product of multi-fetal gestation. Except 
for 1 pregnancy, the rest of the multi-fetal gestations were a product of ovulation 
induction, done for infertility.  
 
 
 
 Antenatal steroids coverage is very low in our study population with only 
24% being fully covered with steroids. 38% did not receive even a single dose of 
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Fig 6: Birth weight vs gestational age
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Fig 7: Chorionicity
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steroid. In our inborn centre, dexamethasone phosphate is alone is administered, 
which is available free of cost to patients. Our study population also had 12% 
who were given betamethasone. These are administered to mothers prior to 
referral here. The high proportion of morbidities and mortalities may be partially 
attributed to the poor steroid coverage.  
 
 
 46% of our study population were born following spontaneous onset of 
preterm labour. 33% have preterm premature rupture of membranes. Also 
surprisingly, we had 4 babies who were induced based on wrong dates. In these 
4 babies, prematurity was diagnosed only after the babies were born. These were 
categorised as ‘iatrogenic prematurity’. They are depicted in Fig 9. 
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Fig 8: Antenatal steroids coverage
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  The analysed risk factors and the prevalence of them in the study 
population are tabulated in table 2. Males predominate in our study population; 
58.5% are males and 41.5% are females. There is also a high incidence of sepsis 
(60.7%). It is quite surprising that 76.6% had growth delay at 1 year.  
Table 2: Prevalence of risk factors amongst study population 
Risk factor Prevalence 
n(%) 
Parent education < middle school 12(6.5) 
Gestational age ≤ 30 wks 98(35.6) 
Primi / no previous preterm 210(76.4) 
Maternal anemia Hb<8 g% 28(10.2) 
Maternal malnutrition Wt<50 kg 85(30.9) 
Risks for early onset sepsis 90(32.7) 
IUGR 71(25.8) 
60, 20%
4, 1%
140, 46%
102, 33%
Fig 9: Etiology of preterm
Indicated Iatrogenic Spontaneous onset of preterm labour pPROM
Male sex 161(58.5) 
SGA 62(22.5) 
Birth weight < 1200 g 77(28.0) 
5” APGAR < 6 45(16.4) 
Indicated preterm 52(18.9) 
Multiple gestation 75(27.3) 
Acute intrapartum hypoxic events 32(11.6) 
Pre-eclampsia 48(17.5) 
Abnormal Doppler 132(48) 
Incomplete / no antenatal steroids 208(75.6) 
Extramural delivery 33(12.0) 
Resuscitated at birth 73(26.5) 
Encephalopathy 62(22.5) 
Ventilated for > 3 days 68(40.7) 
Acute hypoxic events 12(4.4) 
Shock 119(43.3) 
Hypoglycemia 23(8.4) 
Sepsis 167(60.7) 
Hyperbilirubunemia 151(54.9) 
NEC 4(1.5) 
BPD 2(1.1) 
PDA 7(2.5) 
Abnormal neurologic status at discharge 11(6.0) 
IVH 34(12.4) 
Abnormal neurosonogram 18(9.8) 
Growth delay 134(76.6) 
Outcomes 
 DASII at 1 year corrected age was performed for 175 babies. The results are 
tabulated below. There was a major delay in atleast one of Motor Quotient (MoQ) 
or Mental Quotient (MeQ) in 34 (19.2%) babies.  
Table 3: DASII score results 
DASII score 
n=175 
Major delay 
Score <70 
Minor delay 
Score 70-85 
Normal 
Score >85 
Motor Quotient (MoQ) 23 71 81 
Mental Quotient (MeQ) 25 30 120 
Any delay 34 64 77 
 
Primary outcome 
Death or major neurodevelopmental delay is seen in 134 babies (44.1%) 
Table 4: Distribution of primary outcome  
Death or Major NDD 134 (44.1%) 
Normal or minor NDD 141 (46.4%) 
Lost follow up 29 (9.5%) 
Total 304 
 
 
Table 5: Prevalence of primary outcome amongst risk factors 
 
 
Risk factor 
Prevalence % 
of death/major 
NDD if risk + 
If absent 
 
Parent education < middle school 23.8 16.7 
Gestational age ≤ 30 wks 81.6 30.5 
Primi / no previous preterm 52.9 35.4 
Maternal anemia Hb<8 g% 50.0 48.6 
Maternal malnutrition Wt<50 kg 40.0 52.6 
Risks for early onset sepsis 36.7 54.6 
IUGR 46.5 49.5 
Male sex 50.9 45.6 
SGA 41.9 50.7 
Birth weight < 1200 g 79.2 36.9 
5” APGAR < 6 86.7 41.3 
Indicated preterm 51.9 48.0 
Multiple gestation 36.0 53.5 
Acute intrapartum hypoxic events 43.8 49.4 
Pre-eclampsia 56.2 47.1 
Abnormal Doppler 70.5 28.7 
Incomplete / no antenatal steroids 51.0 41.8 
Extramural delivery 30.3 51.2 
Resuscitated at birth 74.0 39.6 
Encephalopathy 66.1 43.7 
Ventilated for > 3 days 64.7 83.8 
Acute hypoxic events 91.7 46.8 
Shock 94.1 14.1 
Hypoglycemia 52.2 48.4 
Sepsis 55.7 38.0 
Hyperbilirubunemia 35.8 64.5 
NEC 75.0 48.3 
BPD 100 22.5 
PDA 100 47.4 
Abnormal neurologic status at discharge 100 18.5 
IVH 79.4 44.6 
Abnormal neurosonogram 88.9 16.3 
Growth delay 24.6 2.4 
 
 The weighted risk score for death or major neurodevelopmental delay is 
tabulated in table 6. In the Univariate model, the risk factors associated with a 
composite outcome of death or major neurodevelopmental disability are 
presence of shock, abnormal neurosonogram, growth delay at 1 year, acute 
hypoxic events (like air leaks or apnea requiring resuscitation), gestational age 
<30 weeks, 5 minute APGAR <6, birth weight <1200 g, abnormal antenatal 
Doppler, abnormal neurologic status at discharge, IVH, BPD, requirement of 
resuscitation at birth, ventilatory requirements > 3 days, encephalopathy, PDA, 
sepsis, and previous preterm, in the order of strength of association. NEC, parent 
education <middle school, incomplete antenatal steroids, preeclampsia, male 
gender, indicated preterm, and hypoglycaemia are also having a trend towards 
poor primary outcome but they are statistically insignificant. Also of particular 
interest is the finding that multiple gestation, risks for early onset sepsis, 
extramural delivery and hyperbilirubinemia are significantly associated with a 
better outcome.  
Table 6: Odds ratio for risk factors associated with poor primary outcome 
Risk factor Significance Odds 
ratio 
95% CI 
Parent education < middle school 0.73 1.57 0.33 7.43 
Gestational age ≤ 30 wks 0.000 10.12 5.54 18.5 
Primi / no previous preterm 0.02 2.05 1.15 3.64 
Maternal anemia Hb<8 g% 1.00 1.06 0.48 2.31 
Maternal malnutrition Wt<50 kg 0.07 0.60 0.36 1.01 
Risks for early onset sepsis 0.007 0.48 0.29 0.81 
IUGR 0.68 0.89 0.52 1.52 
Male sex 0.39 1.24 0.76 2.00 
SGA 0.25 0.70 0.40 1.24 
Birth weight < 1200 g 0.000 6.53 3.51 12.2 
5” APGAR < 6 0.000 9.24 3.76 22.7 
Indicated preterm 0.65 1.17 0.64 2.14 
Multiple gestation 0.01 0.49 0.28 0.84 
Acute intrapartum hypoxic events 0.58 0.80 0.38 1.67 
Pre-eclampsia 0.27 1.44 0.77 2.70 
Abnormal Doppler 0.000 5.93 3.5 10.0 
Incomplete / no antenatal steroids 0.21 1.45 0.83 2.52 
Extramural delivery 0.03 0.41 0.19 0.91 
Resuscitated at birth 0.000 4.33 2.39 7.85 
Encephalopathy 0.002 2.52 1.39 4.55 
Ventilated for > 3 days 0.006 2.83 1.36 5.88 
Acute hypoxic events 0.002 12.5 1.59 98.4 
Shock 0.000 97.5 40.1 237 
Hypoglycemia 0.83 1.16 0.49 2.73 
Sepsis 0.005 2.05 1.25 3.37 
Hyperbilirubinemia 0.000 0.31 0.19 0.50 
NEC 0.36 3.2 0.33 31.2 
BPD 0.054 4.44 3.39 5.81 
PDA 0.006 2.11 1.86 2.39 
Neurologic status at discharge 0.000 5.41 3.95 7.39 
IVH 0.000 4.79 2.01 11.4 
Abnormal neurosonogram 0.000 41.2 8.95 189 
Growth delay 0.003 13.1 1.73 98.8 
 
This is represented in a logarithmic scale in fig. 10. Odds ratio > 1 indicates 
a significant association with a poorer outcome and <1 indicates a significant 
association with a better outcome.  
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Fig. 10: Primary outcome odds ratio for risk factors
Using a step-wise multiple regression analysis, the following risk factors 
are independently associated with a poor outcome. A regression equation can 
be constructed with these 4 risk factors to predict the probability of a poorer 
final outcome.  
Table 7: Multi-step regression analyses of risk factors vs primary outcome 
Risk factor Sig. Exp(B) 
 5” APGAR 0.000 0.084 
Shock 0.000 0.027 
Sepsis 0.05 0.405 
Gestational age  0.000 0.195 
Constant 0.000 14.723 
 
 Gestational age came as a better predictor of poorer neurodevelopmental 
outcome than birth weight.  
Secondary outcome 
Table 8: Distribution of secondary outcome 
Death or any NDD 198 (65.2%) 
Normal 77 (25.3%) 
Lost follow up 29 (9.5%) 
Total 304 
  
Death or any neurodevelopmental delay is seen in 198 babies (65.2%).  
Table 9: Prevalence of primary outcome amongst risk factors  
 
Risk factor 
Prevalence % 
of any NDD if 
risk factor + 
If absent 
 
Parent education < middle school 23.8 16.7 
Gestational age ≤ 30 wks 81.6 30.5 
Primi / no previous preterm 52.9 35.4 
Maternal anemia Hb<8 g% 50.0 48.6 
Maternal malnutrition Wt<50 kg 40.0 52.6 
Risks for early onset sepsis 36.7 54.6 
IUGR 46.5 49.5 
Male sex 50.9 45.6 
SGA 41.9 50.7 
Birth weight < 1200 g 79.2 36.9 
5” APGAR < 6 86.7 41.3 
Indicated preterm 51.9 48.0 
Multiple gestation 36.0 53.5 
Acute intrapartum hypoxic events 43.8 49.4 
Pre-eclampsia 56.2 47.1 
Abnormal Doppler 70.5 28.7 
Incomplete/ no antenatal steroids 51.0 41.8 
Extramural delivery 30.3 51.2 
Resuscitated at birth 74.0 39.6 
Encephalopathy 66.1 43.7 
Ventilated for > 3 days 64.7 83.8 
Acute hypoxic events 91.7 46.8 
Shock 94.1 14.1 
Hypoglycemia 52.2 48.4 
Sepsis 55.7 38.0 
Hyperbilirubunemia 35.8 64.5 
NEC 75.0 48.3 
BPD 100 22.5 
PDA 100 47.4 
Abnormal neurologic status at discharge 100 18.5 
IVH 79.4 44.6 
Abnormal neurosonogram 88.9 16.3 
Growth delay 24.6 2.4 
 
The weighted risk score for secondary outcome is tabulated in table 10.  
Table 10: Odds ratio for risk factors associated with poor secondary outcome 
 
Risk factor p value Odds 
ratio 
95% CI 
Parent education < middle school 0.25 0.44 0.11 1.7 
Gestational age ≤ 30 wks 0 16.5 5.8 47 
Primi / no previous preterm 0.02 2.1 1.2 3.7 
Maternal anemia Hb<8 g% 1 0.9 0.4 2.3 
Maternal malnutrition Wt<50 kg 0.15 0.6 0.4 1.1 
Risks for early onset sepsis 0.03 0.5 0.3 0.9 
IUGR 0 4 1.8 8.9 
Male sex 0.4 1.3 0.7 2.1 
SGA 0 4.7 1.9 11 
Birth weight < 1200 g 0 6.6 2.7 16 
5” APGAR < 6 0 10 2.5 44 
Indicated preterm 0.01 2.9 1.3 6.8 
  
They are depicted in a logarithmic scale in fig. 11. The results are 
comparable with the primary outcome with a few exceptions. Hyperbilirubinemia 
which had a negative association with primary outcome, is positively associated 
with a composite outcome of death or any neurodevelopmental delay but the 
association is insignificant.  
Multiple gestation 0.17 1.6 0.9 3 
Acute intrapartum hypoxic events 0.53 1.4 0.6 3.5 
Pre-eclampsia 0.01 3.2 1.3 7.8 
Abnormal Doppler 0 5.4 2.9 10 
Incomplete / no antenatal steroids 1 1 0.6 1.9 
Extramural delivery 0.06 0.5 0.2 1 
Resuscitated at birth 0.001 3.6 1.7 7.7 
Encephalopathy 0.01 2.7 1.3 5.9 
Ventilated for > 3 days 0.05 3.2 1.1 9.9 
Acute hypoxic events 0.04 1.4 1.3 1.5 
Shock 0 1.9 1.7 2.3 
Hypoglycemia 0.14 2.8 0.8 9.6 
Sepsis 0.002 2.4 1.4 4.1 
Hyperbilirubinemia 0.6 1.2 0.7 2 
NEC 0.3 1.4 1.3 1.5 
BPD 0.5 1.7 1.5 1.9 
PDA 0.2 1.4 1.3 1.5 
Neurologic status at discharge 0.003 1.8 1.6 2.1 
IVH 0 1.5 1.3 1.6 
Abnormal neurosonogram 0 1.9 1.6 2.1 
Growth delay 0 30 8.9 106 
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Fig 11: Secondary outcome - odds for risk factors
 Risks for early onset sepsis (maternal fever or pPROM or 
chorioamnionitis) is the only risk factor which is not associated with a poorer 
neurodevelopmental outcome.   
  
 
 
DISCUSSION 
  
Discussion 
 The outcome is analysed at 1 year in our study though the babies are still 
continuing in our follow up. Our primary outcome is chosen only as ‘major’ 
neurodevelopmental delay because at 1 year, some of the subtle minor outcomes 
have not yet manifested and / or some are over-estimated which can disappear 
over time due to plasticity of the brain. For analysing major neurodevelopmental 
delays, 1 year follow up is acceptable. It has been found that earlier outcome at 
12-24 months has 87% correlation with outcome at 8 years and also during 
adolescence (8, 26, 27). The cognitive outcomes are known to worsen through 
ages 1 to 4 years (9). Though the initial neuromotor status lays the foundation for 
future cognitive development according to Piaget’s theory, the correlation may 
not be accurate. The outcome is more favourable in 10% and less favourable in 
7% at 5 years in a study be Veen at.al. in 1991 (28). In a study by Astbury et.al. , 
it was found that the neurodevelopmental delay also may be under-estimated at 1 
year of age (29). Voss et.al. have concluded that atleast 6 year outcome may be 
necessary to derive meaningful conclusions (30). Also catch-up growth has yet 
to occur fully in our study. We are still following up our babies and further follow 
up may throw more light to our findings. 
The proportion of preterm neonates ≤ 34 weeks in our centre is 21.3%.  
This is high primarily because ours is a referral tertiary care (level 3) centre for 
primary and secondary care centres in and around Chennai. There are rapid 
advances in primary neonatal care through CEmONC (Comprehensive 
Emergency Obstetric and Newborn Care) centres in Tamil Nadu. Only high risk 
mothers and neonates who cannot be managed there, get referred to our Institute.  
The incidence of death or major neurodevelopmental delay, which is the 
primary outcome in our study is 44.1%. Most of the studies from the western 
world even some decades ago, have a very low incidence of poor neurologic 
outcome of <20% (31). But studies from the developing world are entirely 
different. In a study from Bangladesh in 2006, the incidence is 68% in <33 weeks 
preterm babies (18). Because of these huge differences, it might be difficult to 
extrapolate their risks to our population. This justifies our study at our centre. 
Gestational age is one of the independent major determinant of poor 
outcome with a mean odds ratio of 10.1. The effects remained significant even 
after multiple logistic regression. This has been documented in many previous 
studies. In a 2012 review by Xiong et.al., gestational age has been the consistent 
independent risk factor for poor outcome (32). In a study by Andrews et. al. in 
2008, IQ was found to increase by 1.9 points for each week of gestational age 
(33). Though birth weight too had an odds ratio of 6.5, it didn’t come as an 
independent risk factor for poor outcome.  
Most of our babies had growth delay at 1 year of corrected age. This 
implies that catch up growth is still not complete. Our study has a 23% incidence 
of SGA babies. The odds ratio for growth delay is 13.1. This correlation of growth 
delay with poor neuro-developmental outcome was documented in earlier studies 
too (34, 35). In a study by Neubauer et.al., the head size at 3 months was strongly 
associated with poor neurodevelopmental outcome assessed by BSID at 24  
months. The catch up growth can even be delayed up to 8-14 years of age (36). 
Our growth restricted babies also had a typical developmental pattern of more of 
motor delay than mental delay. In a study by Shah et. al., post natal growth failure 
was significantly associated with psychomotor delay (p=0.006) but not with 
cognitive delay (p=0.379)  (37). Our findings are also very similar. These findings 
are partly attributed to hypotonia and muscular weakness associated with growth 
delay.  
Abnormal neurosonogram (cPVL - cystic periventricular leukomalacia) is 
one of the consistent poor prognostic indicator in previous similar studies. The 
odds ratio in univariate analysis is 41.2 which is the highest amongst the risk 
factors. Almost all the studies have similar findings. In the VON network 
study(12), the odds ratio is 5.56 for cPVL and it has the highest predictive ability 
for a poorer outcome. In a study by Fazzi et.al. in 1992, it was found that the 
sonographic abnormalities correlated more closely with neuromotor delay rather 
than cognitive delay(38). Our study had predicted worser outcome in both the 
domains. This is in concurrence with the study by Ballot et.al. in a developing 
country(17), where it is associated with a poorer outcome in all domains.  
5 minute APGAR score < 6 has an odds ratio of 9.24 for predicting death 
or major neurodevelopmental delay. In the VON network study (12), the adjusted 
odds ratio is 2.06 for severe delay. In our study, it is also one of the independent 
predictor of a composite outcome of death or major delay.  
Male gender is associated with a poorer outcome. Regression analyses has 
shown it to be an independent predictor of long term poorer outcome in all the 
network studies (VON, NICHD and EPICure studies) and also in a study done by 
Stoelhorst et.al. (39). But in our study, though there is a trend towards poorer 
outcome, this is not statistically significant. This might be because of the gender 
bias prevailing in the community of our study population. Male babies, even 
when they had mild illness gets referred early due to this bias and hence the 
relatively better outcome when compared with other studies. 
 Neonatal hyperbilirubinemia is surprisingly associated with a better 
neurologic outcome. In a study by Van de Bor et.al. in 1992 (40), it was found 
that the odds ratio for neurodevelopmental impairment is 1.84 if associated with 
severe IVH and 1.05 if without severe IVH. Only 12.4% of our population had 
any grade of IVH and only 1.5% had severe IVH. This is partly due to the fact 
that we use dexamethasone as the preferred choice of antenatal steroid which is 
known to be protective for IVH. So most didn’t have severe IVH and hence the 
the subset of population with both severe IVH and hyperbilirubinemia is very 
small in number. That’s probably the reason why hyperbilirubinemia is not 
associated with death or major neurodevelopmental delay.  But it is associated 
with minor neurodevelopmental delay though not statistically significant. 
 Overall, the strongest association with a poor neurologic outcome with an 
odds ratio of >10 is seen with abnormal neurosonogram, gestational age <30 
weeks, growth delay and acute hypoxic events which include air leaks, apnea 
requiring resuscitation and shock.  
  
  
Strengths of the study 
 This is one of the large single center follow up study. Our institute is the 
apex tertiary care center for all government hospitals in Tamil nadu. So the 
findings of our study can be reasonably extrapolated to the whole of Tamil nadu. 
 We have established a standardised follow up care program in both the 
intramural and extramural center. This will provide the platform for future studies 
on neurodevelopmental follow up of babies discharged from our nursery. 
 There is no inter-observer variability in the outcomes analysed as the 
principal investigator has done all the neurodevelopmental outcome assessment 
by DASII. 
 There are only 13.6% drop-outs from the study, who lost follow up. This 
is within the acceptable limits of <20%. So the clinical findings of this study may 
be considered reliable.   
Limitations of the study 
 This short period of follow-up is one of our primary limitation. The study 
cohort is still under follow up and further long term follow up of these babies may 
throw more light on accurate interpretation of data. 
Implications for clinical use 
 Based on the odds ratio for each risk factor, the clinician can estimate the 
risk of future neurodevelopmental delay at discharge itself. This will help in 
intensifying follow up and early intervention programs for those babies identified 
to be in high risk for neurodevelopmental impairment. On a simpler note, just 
assessing the 4 independent predictors – 5 minute APGAR <6, shock, sepsis and 
gestational age <30 weeks, itself can predict to a reasonable extent a poorer 
outcome. This can be used as a community tool to identify a subset of babies with 
highest risk. These babies require frequent follow up services and can aid the 
government in implementing benefit programmes for such high risk babies.   
   
  
 
CONCLUSION 
  
Conclusion 
 Establishing a standardized follow up program with provision for early 
intervention is advised for all newborn nurseries who care for preterm babies <34 
weeks of gestation.  
 Gestational age ≤30 weeks, 5 minute APGAR <6, presence of sepsis and 
shock are independent risk factors for poor composite outcome of death or major 
neurodevelopmental delay at 1 year of corrected age. 
 Gestational age ≤30 weeks, acute hypoxic events (air leaks, apnea 
requiring resuscitation, hypocapnia), growth delay, abnormal neurosonogram at 
40 weeks and shock are associated with an odds ratio >10 for a poor composite 
outcome of death or major neurodevelopmental delay at 1 year of corrected age. 
 Catch-up growth of preterm babies <34 weeks is inadequate at 1 year of 
corrected age. 
 Long term follow-up is necessary to accurately assess the impact of 
antenatal, perinatal and neonatal risk factors on neurodevelopment.  
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ANNEXURES 
Annexure 1: Clinical signs and laboratory signs for sepsis 
Clinical signs Laboratory signs 
Temperature instability / hypothermia / 
hyperthermia 
Cardiovascular instability (heart rate variations, 
oliguria, hypotension, poor perfusion) 
Skin and subcutaneous lesions (petechiae, 
sclerema) 
Respiratory instability (apnea, tachypnea, 
increasing FIO2 requirements or ventilatory 
support) 
Gastrointestinal instability (feed intolerance, 
poor suck, abdominal distension) 
Non-specific (irritability, lethargy, hypotonia) 
Leukopenia / Leukocytosis 
Thrombocytopenia 
CRP positive 
 
Hypoglycemia / 
hyperglycemia despite 
normal glucose intake 
 
Metabolic acidosis 
 
 
  
Annexure 2: Excel code sheet of patient data 
Explanation of the codes 
Parent education 
1=Profession or honours 
2=Graduate or post graduate 
3=Intermediate or post high school diploma 
4=High school certificate 
5=Middle school certificate 
6=Primary school certificate 
Parity 
1=primi 
2=previous 2nd/3rd trimester fetal loss 
3=previous preterm 
4=no previous adverse events 
Maternal anemia 
1=Hb<6 
2=6-8 
3=>8 
4=normal 
Maternal malnutrition 
1=wt <50 kg 
2=>50 kg 
Risks for sepsis 
1=none 
2=pPROM 
3=maternal fever 
4=clinical chorioamnionitis 
5=2+3 
6=2+4 
Intrauterine growth 
1=no IUGR 
2=asymmetric IUGR 
3=symmetric IUGR 
Sex 
 1=male 
 2=female 
SGA 
1=SGA 
2=AGA 
3=LGA 
5” APGAR 
1=>6 
2=4-6 
3=<4 
Etiology of preterm 
1=spontaneous preterm labour 
2=pPROM 
3=indicated preterm 
4=iatrogenic (wrong dates) 
Twins 
1=singleton 
2=dichorionic twin 
3=monochorionic twin 
4=triplets or higher 
Acute intrapartum events 
1=none 
2=fetal distress 
3=cord complications 
4=abruption 
Preeclampsia 
1=none 
2=preeclampsia 
3=severe preeclampsia 
Abnormal Doppler 
1=normal 
2=cerebral redistribution 
3=AREDF 
4=not done 
A/N steroids 
1=no steroids 
2=partial course dexa 
3=partial course beta 
4=full course dexa 
5=full course beta 
Place of delivery 
1=intramural 
2=extramural 
Resuscitation at birth 
 1=none 
2=requires PPV 
3=requires intubation 
4=requires chest compression 
Encephalopathy 
1=none 
2=perinatal depression 
3=HIE stage 1 
4=stage 2 
5=stage 3 
Duration of ventilation 
1=not ventilated 
2=<3days 
3=3-7 days 
4=>7 days 
Acute hypoxic events 
1=none 
2=air leaks 
3=apnea requiring resuscitation 
4=both 
Shock 
1=no shock 
2=fluid responsive 
3=catecholamine responsive 
4=catecholamine resistant 
Hypoglycemia 
1=no hypoglycemia 
2=<25 mg% 
3=>3 days 
4=symptomatic 
5=asymp >25 and <3d 
Sepsis 
1=no sepsis 
2=screen positive 
3=culture positive 
4=clinical sepsis 
Jaundice 
1=no jaundice 
2=requires phototherapy 
3=requires exchange 
4=has BIND 
NEC 
1=no NEC 
2=stage 1 
3=stage 2 
4=stage 3 
CLD 
1=no BPD 
2=mild BPD 
3=modearte BPD 
4=severe BPD 
PDA 
1=no PDA 
2=closed medically 
3=closed surgically 
Neurologic status at discharge 
1= normal 
2= abnormal 
IVH 
1= no IVH 
2=grade 1 
3=grade 2 
4=grade 3 
PVL 
1=normal 
2=abnormal 
4,8 & 12 month examination 
1=abnormal Denver 
2=abnormal tone  
3=abnormal CDC grading 
4=1+2 
5=1+3 
6=2+3 
7=1+2+3 
8=normal 
DASII MoQ or MeQ 
1= score < 70 
2= 70-85 
3= >85 
Vision 
1=blindness 
2=refractory error / squint 
3=no impairment 
ROP 
1=requires surgery 
2=requires LASER 
3=no treatment required 
4=no ROP 
Hearing 
1=requiring assistive devices 
2=not requiring devices 
3=no impairment 
Growth delay 
1= normal 
2= grade 1 PEM 
3= grade 2 
4= grade 3 
5= grade 4 
Hypothyroidism 
1= present 
2= absent 
Death 
1=death 
2=survived 
3=lost follow up 
  
 Name Parent 
education 
(best) 
Gestational 
age 
(weeks) 
Parity Maternal 
anemia 
Maternal 
malnutrition 
Risks 
for 
sepsis 
Abnormal 
Intrauterine 
growth 
Sex SGA Birth 
weight 
(grams) 
5" 
APGAR 
Etiology 
of 
preterm 
Twins Acute 
intrapartum 
hypoxic 
events 
Preeclampsia Abnormal 
Doppler 
A/N 
steroids 
Place of 
delivery 
Resuscitation 
at birth 
Encephalopathy Duration 
of 
ventilation 
Acute 
hypoxic 
events 
Shock Hypoglycemia Sepsis Jaundice NEC CLD PDA Neurologic 
status at 
discharge 
IVH PVL 4 month 
examination 
8 month 
examination 
1 year 
examination 
DASII 
MoQ 
DASII 
MeQ 
Vision ROP Hearing Growth 
delay 
at 1 
year 
Hypothyroidism Death 
Padmavathy 6 28 4 3 1 1 1 1 2 910 1 3 1 2 2 3 5 2 1 1 2 1 4 1 2 1 1 1 1 2 2 1          2 1 
Kowsalya 5 34 2 3 1 1 2 2 1 1220 1 3 1 4 2 4 1 2 1 1 1 1 1 1 4 2 1 1 1 2 2 2          2 1 
Rabiya 5 33 1 3 2 1 1 1 2 1760 1 1 1 3 1 4 3 2 2 4 2 1 3 1 4 2 1 1 1 2 3 2          2 1 
Mahalakshmi 2 2 29 1 4 2 1 1 1 2 1245 1 1 2 1 1 1 3 2 1 1 3 1 3 1 4 2 1 1 1 2 2 1          2 1 
Anusya 2 27 1 3 2 1 1 1 2 1075 1 1 1 1 1 1 2 1 1 1 4 3 3 5 4 2 1 2 2 2 3 2          2 1 
Vijayalakshmi 
3 
5 34 1 3 2 1 2 2 1 1425 2 3 4 1 2 2 2 1 2 2 3 1 3 5 4 2 1 1 1 1 2 1          2 1 
Ilamathi 3 5 33 2 4 2 1 1 1 1 1000 2 3 4 1 3 3 4 1 3 2 3 1 4 1 4 2 1 1 1 1 3 1          2 1 
Kavitha 1 5 34 1 4 2 2 2 1 1 1235 1 2 4 1 1 3 5 1 2 2 4 3 4 4 4 2 1 1 2 1 4 2          2 1 
Sivagami 5 33 2 3 1 2 1 2 2 1980 1 2 1 1 1 1 2 1 1 1 1 1 1 1 3 1 1 1 1 2 1 1          2 1 
Yasmin  32 1 3 2 1 1 1 2 2160 1 3 1 1 1 1 1 1 2 2 3 1 4 1 4 1 1  1  3            1 
Mumtaj Begum 32 1 3 1 1 2 1 1 1155 1 3 1 1 3 4 2 1 1 1 2 1 4 1 4 1 1  1  4            1 
Shakila  29 4 3 2 1 1 2 2 1320 3 3 1 4 3 1 1 1 3 2 3 1 4 1 4 2 1  1  1            1 
Vimala  29 1 3 2 2 1 1 2 1250 3 2 1 1 1 4 1 1 3 2 4 1 4 1 4 2 1  2  2            1 
Rohini  32 1 2 1 1 2 2 1 1065 1 3 1 2 2 2 2 1 2 2 3 1 4 1 4 1 1  1  1            1 
Sheela  26 1 3 2 1 1 1 2 935 2 1 1 1 1 1 1 1 2 2 4 1 4 1 4 2 1  1  4            1 
Amudha 1 29 1 3 2 2 1 2 2 1065 1 2 3 1 1 1 1 1 2 2 2 1 4 1 4 2 1  1  1            1 
Selvi  31 2 3 2 2 2 1 1 1160 1 2 1 1 1 1 2 1 1 1 4 1 4 1 4 2 1  1  1            1 
Rohini  30 1 2 1 1 2 2 1 880 1 3 1 1 3 4 1 1 2 2 2 1 4 1 4 1 1  1  3            1 
Kiran  27 1 3 2 2 1 2 2 890 3 2 1 1 1 4 1 1 4 2 2 1 3 1 1 1 1  1  1            1 
Booma 3  27 1 3 2 2 1 2 2 860 1 2 4 1 1 4 4 1 1 1 2 1 3 1 1 1 1  1  1            1 
Booma 1  27 1 3 2 2 2 1 1 700 2 2 4 1 1 4 4 1 1 1 2 1 3 1 1 1 1  1  1            1 
Booma 4  27 1 3 2 2 2 1 1 765 1 2 4 1 1 4 4 1 1 1 2 1 3 1 1 1 1  1  1            1 
Gulsar  29 1 3 2 1 1 2 2 995 2 3 1 1 3 4 5 1 2 2 2 1 3 1 1 1 1  1  1            1 
Rosy  30 1 3 2 1 1 1 2 1325 1 1 1 1 1 4 1 1 2 1 4 1 3 1 3 1 1  1  4            1 
Janani 2  31 1 3 2 1 1 1 2 1470 1 3 1 4 1 4 1 1 1 1 3 1 3 1 4 1 1  1  1            1 
Sangeetha 26 1 3 1 2 1 1 2 765 3 2 1 1 1 4 3 1 3 2 2 1 3 1 1 1 1  1  4            1 
Sudha  33 1 3 2 2 1 2 2 1580 1 2 1 1 1 4 2 1 1 1 3 2 3 1 1 1 1  1  1            1 
Roshan bee 33 2 2 1 1 2 2 1 1285 1 3 1 1 1 4 1 1 1 1 2 1 3 1 1 1 1  1  1            1 
Sripriya  32 1 3 2 1 2 2 2 1260 3 3 1 2 3 2 4 1 3 2 2 1 3 1 1 1 1  1  1            1 
Hasena  30 4 3 2 1 2 1 2 1105 2 2 1 1 1 1 1 1 3 2 2 1 3 1 1 1 1  1  1            1 
Karpagam 27 2 3 2 1 2 2 2 945 1 1 1 1 1 1 1 1 2 2 2 1 3 1 1 1 1  1  1            1 
Jayanthi  27 1 3 2 1 1 1 2 1030 1 1 1 2 1 1 1 1 1 1 4 1 3 1 4 2 3  1  1            1 
Nirmala  30 1 3 2 1 1 2 2 1845 1 1 1 1 1 1 1 1 2 1 3 1 3 1 1 1 1  1  1            1 
Vidhyalakshmi 3 28 1 3 2 1 1 1 2 1195 2 1 4 1 1 4 2 1 2 1 3 1 3 1 1 1 1  1  1            1 
Vedhavalli 30 1 2 1 1 2 2 1 710 1 3 1 1 3 4 5 1 1 1 4 1 3 1 1 1 1  1  1            1 
Priyadharshini 26 1 3 2 1 1 1 2 980 3 1 1 1 1 4 1 1 4 2 3 1 3 1 1 1 1  1  1            1 
Amala  29 2 3 2 1 1 2 2 1285 1 2 3 1 1 4 1 1 1 1 2 1 3 1 1 1 1  1  1            1 
Lalitha  29 1 3 2 1 1 1 2 1000 1 1 1 1 1 4 4 1 1 1 2 2 3 1 1 1 1  1  1            1 
Aswini  29 1 3 2 2 1 1 2 1140 1 1 1 1 1 4 2 1 1 1 3 1 4 1 1 1 1  1  1            1 
Lakshmi  27 1 3 2 2 1 1 2 1105 1 1 1 1 1 4 1 1 1 1 3 1 3 1 1 1 1  1  4            1 
Revathi 2  32 1 3 2 1 1 1 2 1230 1 1 2 1 1 4 1 1 1 1 4 1 4 1 3 2 1  1  1            1 
Sangeetha 1 32 1 3 2 1 2 1 1 1240 1 2 2 1 1 2 1 1 1 1 3 1 3 1 1 2 1  1  1            1 
Clara sundari 31 1 3 2 1 1 1 2 1805 1 1 1 1 1 4 1 1 1 1 3 1 3 1 3 1 1  1  1            1 
Gnanasoundari 31 1 3 2 1 1 1 2 1710 1 1 1 1 1 4 1 1 1 1 4 1 3 1 3 1 1  1  1            1 
Sandhya  32 1 3 2 1 1 1 2 1330 1 1 1 1 1 4 1 1 1 1 4 1 3 1 3 1 1  1  4            1 
Lavanya  29 1 3 2 1 1 1 2 1150 1 1 1 1 1 4 1 1 1 1 3 1 3 1 3 1 1  1  1            1 
Uma 1  30 1 3 1 1 2 1 1 975 1 1 2 1 1 2 1 1 1 1 3 1 3 1 3 2 1  1  4            1 
Uma 2  30 1 3 2 1 2 1 2 1060 1 1 1 1 1 4 1 1 3 2 3 1 4 1 1 1 1  1  1            1 
Bhuvaneswari 1 25 1 3 1 1 1 2 2 810 1 1 1 1 1 4 1 1 1 1 3 1 3 1 1 1 1  1  1            1 
Bhuvaneswari 2 25 1 3 1 1 1 2 2 855 1 1 1 1 1 4 1 1 1 1 3 1 3 1 1 1 1  1  1            1 
Divya  30 1 3 2 1 1 2 2 1140 1 1 1 1 1 4 1 1 1 1 3 1 3 1 1 1 1  1  1            1 
Bhanvani  32 1 3 2 2 1 2 2 1400 3 1 1 1 1 4 1 1 3 1 3 1 3 1 1 1 1  1  1            1 
Vijayammal 34 1 3 2 1 2 2 2 2030 1 1 1 1 1 4 1 1 1 1 3 1 3 1 1 1 1  1  1            1 
Malathi  29 1 3 2 1 1 1 2 1275 3 1 1 1 1 4 1 1 3 2 3 1 3 1 1 1 1  1  1            1 
Padmavathy 28 1 3 1 1 1 1 2 915 1 1 1 1 1 1 1 1 1 1 2 1 3 1 1 1 1  1  1            1 
Venmathi 32 1 3 2 1 1 1 2 1480 1 2 1 1 1 1 1 1 1 1 3 1 3 1 1 1 1  1  1            1 
Tamilarasi 2 32 1 3 1 1 2 1 1 770 1 1 3 1 1 3 1 1 1 1 2 1 3 1 1 1 1  1  1            1 
Anjalai  31 1 3 2 1 1 1 2 1410 3 1 1 1 1 1 1 1 3 1 3 1 3 1 1 1 1  1  1            1 
Rukmani  30 1 3 1 1 2 1 1 975 1 1 1 1 1 2 1 1 1 1 2 1 3 1 1 1 1  1  1            1 
Sukartha  30 1 3 2 1 1 1 2 1485 3 1 1 1 1 1 1 1 3 1 2 1 3 1 1 1 1  1  1            1 
Jansi  26 1 3 2 1 1 1 2 910 3 1 1 1 1 4 1 1 3 1 3 1 3 1 3 1 1  1  1            1 
Dhanaselvi 34 1 3 2 1 1 2 2 2380 1 1 1 1 1 1 2 1 1 1 4 1 3 1 1 1 1  1  1            1 
Zakiri  28 1 3 2 1 1 2 2 935 1 2 1 1 1 1 2 1 1 1 3 1 3 1 1 1 1  1  1            1 
Yasmin  32 1 3 2 1 1 2 2 1780 1 1 1 1 1 1 2 1 1 1 3 1 4 1 3 2 1  1  1            1 
Punitha  27 1 3 2 1 1 2 2 1195 1 2 1 1 1 1 2 1 1 1 3 1 4 1 1 1 1  1  1            1 
Regina  28 1 3 2 1 1 1 2 1035 1 1 1 1 1 4 2 1 1 1 2 1 3 1 1 1 1  1  1            1 
Sundari  27 1 3 2 1 1 1 2 825 1 1 1 1 1 4 2 1 1 1 3 1 3 1 1 1 1  1  1            1 
Sumathi  28 1 3 2 1 1 1 2 965 1 1 1 1 1 1 2 1 1 1 3 1 3 1 1 1 1  1  1            1 
Bama  30 1 3 1 1 1 2 2 1165 1 3 1 2 3 1 1 1 2 2 4 1 3 1 4 2 1  1  1            1 
Karthigaselvi 28 2 3 2 1 1 1 2 1180 2 3 1 4 1 1 1 1 3 2 2 1 1 1 1 1 1  1  1            1 
Bharathi 1 29 1 3 2 1 1 1 3 1740 1 1 3 1 1 4 1 1 2 1 2 1 3 1 2 1 1  1  1            1 
Devipriya  31 1 4 2 1 1 2 2 1640 3 1 1 1 3 4 2 1 1 1 2 1 3 1 2 1 1  1  1            1 
Ammu  30 2 3 2 1 1 1 2 1330 1 1 1 1 1 4 1 1 2 1 3 1 4 1 2 1 1  1  1            1 
Bharathi 2 29 1 3 2 1 1 1 2 1130 1 1 3 1 1 4 1 1 1 1 3 1 3 1 2 1 1  1  1            1 
Menaka devi 32 1 4 2 1 1 1 2 1475 3 1 1 1 3 4 1 1 1 1 2 1 3 1 2 1 1  1  1            1 
Chandrakala 1 31 1 3 2 1 2 1 1 760 1 1 1 1 3 4 4 1 1 1 3 3 3 1 2 1 1  1  1            1 
Chitra 2  32 1 3 1 1 2 1 1 1070 1 1 1 1 3 4 5 1 1 1 3 1 3 1 2 1 1  1  1            1 
Priya 2  26 1 2 2 1 2 1 1 525 2 1 1 1 1 4 1 1 1 1 2 1 3 1 2 1 1  1  1            1 
Diana  26 1 3 2 1 1 2 2 635 1 1 1 1 1 4 1 1 2 2 2 1 3 1 2 1 1  1  1            1 
Yasmin  30 2 3 2 1 1 1 2 1495 1 1 1 1 1 4 1 1 2 1 3 1 3 1 2 1 1  1  1            1 
Dhanalakshmi 32 1 3 2 1 1 2 2 1410 2 1 1 1 1 4 1 1 3 1 2 1 3 1 2 1 1  1  1            1 
Usharani  30 1 3 2 1 1 2 2 1285 2 1 1 1 1 4 1 1 2 1 2 1 3 1 2 1 1  1  1            1 
Chandrakala  29 1 3 1 1 2 2 1 815 1 1 1 1 3 4 4 1 1 1 4 1 3 1 2 1 1  1  1            1 
Priya 1  27 1 2 2 1 1 2 2 700 2 1 2 1 1 4 1 1 1 1 4 1 3 1 2 2 1  1  1            1 
Sujatha  31 2 4 2 2 1 2 2 1440 1 2 1 1 3 4 4 1 1 1 3 1 3 1 4 2 1  1  1            1 
Chandrakala 26 2 4 2 1 1 1 3 1325 1 1 1 1 1 4 2 1 2 1 3 1 4 1 2 1 1  1  1            1 
Monika  30 1 3 2 1 1 2 2 1310 3 1 1 1 3 4 1 1 1 1 2 1 3 1 2 1 1  1  1            1 
Valarmathi 30 1 2 1 1 1 1 2 1115 2 1 1 1 1 4 2 1 1 1 3 1 4 1 2 1 1  1  1            1 
Ananthi  33 4 3 2 2 1 1 3 2770 1 2 1 1 1 4 1 1 1 1 3 1 3 1 4 1 1  1  1            1 
Kowsalya  27 1 3 2 1 1 1 2 700 1 1 1 1 1 4 1 1 1 1 2 1 3 1 2 1 1  1  1            1 
Muruganandhi 2 29 2 3 2 2 1 2 2 1380 1 2 2 1 1 4 1 1 2 2 3 2 3 1 4 1 1  1  1            1 
Ramya  30 1 4 2 1 1 2 2 1250 1 3 1 1 3 4 1 1 1 1 2 1 3 1 2 1 1  1  1            1 
Jayalakshmi 31 4 3 2 1 1 1 2 1940 2 2 1 1 1 4 2 1 2 2 3 1 3 1 2 1 1  1  1            1 
Devi  26 1 2 1 1 1 1 2 945 1 1 1 1 1 4 1 1 1 1 3 1 3 1 2 1 1  1  1            1 
Shakila  31 3 3 2 2 1 1 2 1650 1 2 1 1 1 4 4 1 1 1 4 3 4 1 4 1 1  1  1            1 
Shakila  33 1 3 2 1 2 1 1 1250 1 1 1 1 1 3 1 1 1 1 3 1 3 1 2 1 1  1  1            1 
Poongavanam 2 33 1 3 1 2 2 2 1 1245 1 1 1 1 1 4 1 1 1 1 4 1 4 1 4 2 1  2  1            1 
Farhana  29 4 3 2 1 1 1 2 1245 1 3 1 1 3 4 1 1 1 1 3 1 3 1 2 1 1  1  1            1 
Sujatha  31 2 4 2 2 1 2 2 1440 1 2 1 1 3 4 4 1 1 1 3 1 3 1 4 2 1  1  1            1 
Chandrakala 26 2 4 2 1 1 1 3 1325 1 1 1 1 1 4 2 1 2 1 3 1 4 1 2 1 1  1  1            1 
Amudha 2 32 1 3 1 1 2 1 1 1480 1 1 1 1 1 4 1 2 1 1 1 1 1 4 4 2 1 1 1 1 1 2 8 8 8 2 3 3 4 3 3 2 2 
Ramya 2 32 1 4 2 2 1 1 2 1664 1 2 1 1 1 4 1 2 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 3 3 4 3 2 2 2 
Nalini 2 29 1 2 1 1 1 1 3 1750 1 1 1 1 1 4 3 2 1 1 3 1 3 1 2 2 1 1 1 2 1 2 2 7 7 1 1 2 2 3 4 2 2 
Kokila 5 33 4 3 2 1 1 1 2 1740 1 1 1 1 1 4 5 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Nirmala 5 34 1 3 1 2 2 1 1 1530 1 2 1 1 1 1 1 2 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 3 2 2 
Anitha 5 29 1 3 1 1 1 1 2 1100 1 3 1 4 2 4 1 2 1 4 3 1 3 1 3 2 1 1 1 1 2 1 8 8 2 2 2 3 2 3 3 2 2 
Vasuki 5 34 1 4 1 1 2 2 1 1620 1 1 1 1 1 4 1 2 1 1 1 1 1 1 4 2 1 1 1 1 1 1 8 8 8 2 3 3 4 3 4 2 2 
Suganthi 1 1 32 1 3 1 1 1 1 2 1700 1 3 3 4 3 1 2 2 1 1 1 1 1 1 3 2 1 1 1 1 2 1 8 8 8 3 2 3 4 3 2 2 2 
Suganthi 2 1 32 1 3 1 1 1 1 2 1600 1 3 3 4 3 1 2 2 1 1 1 1 1 1 3 2 1 1 1 1 2 1 8 8 8 2 2 3 4 3 3 2 2 
Mahalakshmi 1 2 29 1 4 2 1 1 2 2 1300 1 1 2 1 1 1 3 2 1 1 2 1 1 1 4 2 1 1 1 1 1 1 8 4 4 2 1 3 4 3 3 2 2 
Priyanka 3 32 1 3 2 1 2 2 1 1100 1 3 1 2 2 2 5 2 1 2 2 1 1 1 2 2 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Christiya 5 32 3 1 1 1 2 1 2 1440 1 1 1 1 1 4 1 2 1 3 1 1 1 5 1 2 1 1 1 1 1 2 8 2 2 2 1 3 3 3 3 2 2 
Girija 4 31 1 3 2 1 1 1 2 1685 1 1 1 1 1 4 2 2 1 1 1 1 1 1 2 2 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Roja 4 30 1 3 1 1 1 1 2 1320 1 3 1 2 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Sumathi 4 31 4 3 1 2 1 2 2 1120 1 2 1 1 1 1 3 2 2 3 2 1 1 1 2 2 1 1 1 1 1 1 8 1 5 1 3 3 3 3 3 2 2 
Kanimozhi 4 34 2 3 2 1 1 1 2 2400 1 4 1 1 1 1 1 2 1 1 2 1 1 3 4 2 1 1 1 1 1 1 8 8 2 2 3 3 4 3 1 2 2 
Ammu 4 31 1 3 1 1 1 2 2 1450 1 1 1 1 1 1 1 2 1 1 1 1 1 5 1 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Shailaja 2 31 1 1 2 1 1 2 2 1270 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Chinnakka 5 32 4 3 1 1 1 1 2 1700 1 1 1 1 1 4 3 2 1 1 3 1 1 1 4 2 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Kanimozhi 3 32 1 3 1 1 1 1 2 1550 1 1 1 1 1 4 1 2 1 1 2 1 1 1 4 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 4 2 2 
Priya 2 34 1 3 2 1 2 2 1 1390 1 1 1 1 1 2 1 2 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 2 3 3 4 3 3 2 2 
Saraswathi 5 31 1 3 1 2 1 1 2 1340 2 2 1 1 1 1 2 2 3 3 3 1 1 1 4 2 1 1 1 1 1 2 2 2 7 1 2 3 2 3 4 2 2 
Bharathi 1 29 1 4 2 1 1 1 2 1200 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Padmavathy 4 32 1 3 1 1 1 1 2 1630 1 1 1 1 1 4 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 4 3 2 2 2 
Govindammal 6 33 3 3 1 1 2 2 1 1490 1 1 1 1 1 4 1 2 1 1 1 1 1 1 4 2 1 1 1 1 1 1 8 8 8 3 3 3 4 3 4 2 2 
Dhanalakshmi 5 32 1 4 1 1 1 2 2 1900 1 1 1 1 1 1 1 2 1 1 2 1 1 1 2 2 1 1 1 1 1 1 8 8 8 3 3 3 4 3 2 2 2 
Samayapurathal 4 30 1 3 1 1 1 1 2 1400 1 1 1 1 1 1 1 2 1 1 2 1 1 1 4 2 1 1 2 1 2 1 8 2 7 1 1 3 2 3 3 2 2 
Anitha 1 5 32 1 4 1 1 1 1 2 1600 1 1 2 1 1 1 1 2 1 1 1 1 1 5 1 2 1 1 1 1 1 1 8 8 8 3 3 3 4 3 2 2 2 
Anitha 2 5 32 1 4 1 1 2 2 2 1460 1 1 2 1 1 1 1 2 1 1 1 1 1 5 1 2 1 1 1 1 1 1 8 8 8 3 3 3 4 3 2 2 2 
Arunakumari 2 32 4 3 2 2 1 2 2 1600 1 2 1 1 1 1 4 1 1 1 3 1 1 1 2 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Sweetarani 4 31 1 2 2 1 1 1 2 1310 1 1 1 1 1 1 1 1 1 1 2 1 3 2 3 3 1 1 1 1 1 1 8 5 5 2 1 3 2 3 3 2 2 
Bakkiyam 5 31 1 3 1 1 1 2 2 1435 1 1 1 1 1 1 1 1 1 1 2 1 1 1 4 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Mohana 1 32 1 4 2 1 1 1 2 1965 2 1 1 1 1 1 2 1 2 2 4 1 3 1 4 2 1 1 1 1 2 1 8 8 1 2 2 3 2 3 2 2 2 
Gomathi 5 31 4 2 1 3 1 2 2 1420 1 2 1 1 1 1 1 1 1 1 2 1 1 1 4 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 3 2 2 
Lalitha 1 4 32 1 3 2 2 2 1 2 1380 1 2 3 1 1 1 1 1 2 2 3 1 1 1 2 2 1 1 1 1 1 1 8 8 8 2 2 3 3 3 3 2 2 
Lalitha 2 4 32 1 3 2 2 2 1 1 1350 1 2 3 1 1 1 1 1 2 2 1 1 1 1 2 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 3 2 2 
Lakshmi 1 5 29 1 3 2 1 1 1 2 1080 1 1 2 1 1 4 2 1 2 2 2 1 1 1 2 2 1 1 1 1 1 1 8 8 5 2 1 3 2 3 3 2 2 
Priya 4 29 1 3 1 1 1 1 2 1455 2 3 1 2 1 4 3 1 3 3 3 1 3 1 4 2 1 1 1 1 1 1 5 5 5 1 1 3 2 3 3 2 2 
Saritha 1 5 31 4 4 2 2 1 1 2 1405 3 2 2 1 1 1 3 1 3 3 3 1 1 1 4 2 1 1 1 1 2 1 5 7 7 1 1 3 2 3 2 2 2 
Saritha 2 5 31 4 4 2 2 1 1 2 1700 2 2 2 1 1 1 3 1 2 2 2 1 1 1 2 2 1 1 1 1 1 1 8 5 7 2 1 3 2 3 2 2 2 
Bhavani 1 5 31 1 3 2 1 1 1 2 1470 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 1 2 2 
Bhavani 2 5 31 1 3 2 1 1 1 2 1120 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1  1 8 8 8 3 3 3 3 3 2 2 2 
Shakila 5 29 2 3 2 2 1 1 2 1130 1 2 1 1 1 4 5 1 1 1 2 1 1 1 2 2 1 1 1 1 1 1 8 8 8 2 3 3 2 3 3 2 2 
Ammu 3 29 1 4 2 1 1 2 2 1100 1 1 1 1 1 4 2 1 1 1 2 1 1 1 4 2 1 1 1 1 1 1 8 8 8 2 2 3 2 3 2 2 2 
Bhuvana 3 34 3 3 2 1 1 1 3 3305 1 3 1 1 1 4 2 1 1 1 1 1 3 4 3 2 1 1 1 1 3 2 8 5 5 2 2 3 3 3 3 2 2 
Revathi 5 34 1 4 2 1 2 2 1 1595 2 1 1 4 1 4 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Jayanthi 5 34 3 3 1 1 1 2 2 2000 1 1 1 1 1 1 5 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Manju 2 5 34 4 3 2 1 1 2 2 2100 1 1 2 1 1 1 4 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Manju 1 5 34 4 3 2 1 1 2 1 1640 1 1 2 2 1 3 4 1 1 1 2 1 1 1 1 2 1 1 1 1 1 1 8 8 8 2 2 3 3 3 2 2 2 
Janet Julie 2 34 1 2 2 1 2 1 1 1640 2 3 1 2 2 3 5 1 2 2 2 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 2 3 3 3 2 2 2 
Chitra 4 33 1 3 1 2 1 1 2 1805 1 2 1 1 1 1 2 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Sowthamani 1 32 4 4 2 1 1 1 2 1810 1 4 1 1 1 1 4 1 2 2 2 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Viji 2 32 1 3 2 1 2 1 1 1000 2 3 1 1 3 3 5 1 3 3 3 1 3 5 2 2 1 1 1 1 1 1 5 5 7 1 1 3 2 3 3 2 2 
Revathi 1 2 29 1 3 2 2 1 1 2 1265 1 2 2 1 1 1 2 1 2 2 2 1 1 1 1 2 1 1 1 1 1 1 8 8 8 2 3 3 2 3 2 2 2 
Jagadeeswari 1 1 31 4 3 2 1 1 2 2 1395 1 1 2 1 1 1 2 1 1 1 1 1 1 1 2 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 2 2 2 
Jagadeeswari 2 1 31 4 3 2 1 1 2 2 1320 1 1 2 1 1 1 2 1 1 1 1 1 1 1 2 2 1 1 1 1 1 1 8 8 8 2 2 3 3 3 2 2 2 
Rathi 5 34 4 4 2 2 1 1 2 2275 1 2 1 1 1 1 2 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Kalaiarasi 2 33 3 3 1 2 1 2 2 2215 1 2 1 1 1 1 2 1 1 1 2 1 1 1 4 1 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Vijayalakshmi 
2 
5 34 1 3 2 1 2 1 1 1360 1 3 4 1 2 2 2 1 1 1 1 1 1 5 1 2 1 1 1 1 1 1 8 8 8 2 2 3 3 3 3 2 2 
Vijayalakshmi 
1 
5 34 1 3 2 1 2 1 1 1245 1 3 4 1 2 2 2 1 1 1 1 1 1 3 2 2 1 1 1 1 1 1 8 8 1 2 3 3 3 3 3 2 2 
Priya 6 31 1 2 1 5 1 1 2 1470 1 2 1 1 2 4 2 1 2 2 1 1 1 1 3 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Supriya 5 34 1 3 1 1 1 1 2 1960 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 1 2 2 
Shanthi 2 33 1 3 2 2 1 1 2 2060 1 2 1 1 1 1 2 1 1 1 3 1 1 1 2 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Malini 4 34 1 3 2 1 1 1 2 2180 1 1 1 1 1 1 4 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Dhanalakshmi 1 2 34 1 3 1 1 2 1 1 1365 1 3 2 1 1 1 2 1 1 1 1 1 1 5 1 2 1 1 1 1 1 1 8 8 8 2 2 3 3 3 3 2 2 
Dhanalakshmi 2 2 34 1 3 1 1 1 2 2 2160 1 3 2 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Usha 2 33 1 3 1 2 1 1 2 1870 1 2 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 1 2 2 
Malathi 1 4 33 1 3 2 2 1 2 2 1770 1 2 2 1 1 1 5 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 1 2 2 
Malathi 2 4 33 1 3 2 2 1 2 2 1925 1 2 2 1 1 1 5 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 1 2 2 
Kavitha rani 1 30 1 3 2 2 1 1 2 1665 1 2 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 1 2 2 
Surya 4 33 1 3 2 2 1 1 2 2155 1 2 1 1 1 1 1 2 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Anbarasi 2 33 4 3 2 2 1 1 2 2000 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 3 3 4 3 2 2 2 
Kavitha 4 33 1 3 1 1 1 2 2 1840 1 3 1 2 3 1 1 1 1 1 2 1 1 1 4 2 1 1 1 1 1 1 8 8 8 3 3 3 4 3 2 2 2 
Rekha 5 34 3 3 1 2 2 1 1 1700 1 2 1 1 1 1 1 1 1 1 2 1 1 1 2 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 3 2 2 
Nagalakshmi 4 33 2 3 1 2 1 2 2 1785 1 2 1 1 1 4 5 1 2 2 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Amudha 6 31 4 3 1 2 1 1 2 1370 1 2 1 1 1 4 2 1 1 1 2 1 3 1 1 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 3 2 2 
Vijayalakshmi 
1 
1 32 2 3 2 2 1 1 2 1670 1 2 2 1 1 1 2 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 1 2 2 
Vijayalakshmi 
2 
1 32 2 3 2 2 1 2 1 1220 1 2 2 1 1 1 2 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 2 2 2 
Tamilarasi 7 34 2 3 1 1 2 2 1 1345 1 3 1 1 3 2 4 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 2 2 3 3 3 3 2 2 
Pushpa 1 3 31 1 3 2 1 1 2 2 1415 1 1 2 1 1 4 1 1 1 1 1 1 1 1 4 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Pushpa 2 3 31 1 3 2 1 1 2 2 1705 1 1 2 1 1 4 1 1 1 1 1 1 1 1 4 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Abirami 5 32 1 3 2 1 2 1 1 930 1 3 1 1 1 3 3 1 1 1 3 1 1 3 4 2 1 1 1 1 2 1 8 8 1 2 1 3 2 3 4 2 2 
Sripriya 3 28 4 4 2 2 1 1 2 1245 1 2 1 1 1 1 4 1 2 2 3 1 3 1 3 2 2 1 1 1 1 1 8 5 5 2 1 3 2 3 3 2 2 
Revathi 5 33 1 3 1 1 2 2 2 1675 1 3 1 1 1 2 4 1 1 1 2 1 1 4 4 1 1 1 1 1 1 1 8 5 5 2 1 3 3 3 2 2 2 
Sangeetha 1 5 34 4 3 1 2 2 1 1 1280 1 2 2 1 1 2 4 1 2 2 1 1 1 1 2 2 1 1 1 1 1 1 8 8 8 2 2 3 3 3 3 2 2 
Devi 5 33 4 3 1 1 1 2 2 1760 3 3 1 4 2 4 1 1 3 2 3 1 1 1 4 1 1 1 1 1 1 2 5 5 7 1 1 3 2 3 3 2 2 
Priyanka 3 34 1 3 2 2 1 1 2 2130 1 2 1 1 1 1 2 1 1 1 1 1 1 1 2 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Banupriya 4 31 1 4 2 2 2 1 1 1205 1 2 1 2 1 1 2 1 1 1 1 1 1 1 4 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 3 2 2 
Neethidevi 1 3 32 1 3 2 1 2 2 1 1305 1 3 3 2 3 4 5 1 1 1 2 1 1 1 4 1 1 1 1 1 1 1 8 8 8 2 3 3 3 3 3 2 2 
Anitha 5 29 4 1 1 1 1 1 2 1590 1 3 1 1 3 1 4 1 1 1 1 1 1 4 4 2 1 1 1 1 1 1 8 5 5 2 1 3 2 3 3 2 2 
Indhumathi 3 33 3 3 2 1 2 1 1 1470 1 3 1 1 3 2 1 1 1 1 1 1 1 1 4 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 2 2 2 
Srividhya 5 33 4 3 2 1 2 2 1 1370 1 3 1 1 3 4 2 1 1 1 2 1 1 1 4 1 1 1 1 1 1 1 8 8 8 2 3 3 3 3 3 2 2 
Siddhi Fathima 1 32 4 4 2 2 1 1 2 1625 1 2 1 1 1 1 5 1 1 1 2 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 1 2 2 
Valarmathi 5 33 3 3 2 5 1 1 2 2135 1 2 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 1 2 2 
Eswari 5 32 1 4 2 1 1 2 2 2010 1 1 1 2 1 1 4 1 2 1 2 1 1 1 4 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Indra 4 33 1 3 2 2 1 1 2 1965 1 2 1 2 1 1 1 1 2 2 3 1 1 1 2 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Latha 7 34 3 2 1 1 1 1 2 2070 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 2 3 3 3 3 3 2 2 
Latha 1 6 31 1 4 2 2 1 2 2 1485 1 2 2 1 1 1 4 1 1 1 3 1 1 1 4 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 2 2 2 
Latha 2 6 31 1 4 2 2 1 2 2 1235 2 2 2 1 1 1 4 1 1 1 3 1 1 1 4 2 1 1 1 1 1 1 8 8 8 2 2 3 3 3 2 2 2 
Sasikala 1 4 33 4 4 2 2 1 1 2 1635 1 2 2 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 1 2 2 
Sasikala 2 4 33 4 4 2 2 1 1 2 1690 1 2 2 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 1 2 2 
Shakila 4 31 4 3 1 2 1 1 2 1650 1 2 1 1 1 1 2 1 1 1 1 1 1 1 2 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Vinodhini 2 30 1 4 2 2 1 2 2 1445 1 2 1 1 1 1 2 1 1 1 2 1 3 1 4 2 1 1 1 1 1 2 5 5 5 2 1 3 2 3 4 2 2 
Manjula 2 32 4 3 2 2 1 2 2 1870 1 2 1 1 1 1 2 1 1 1 1 1 1 1 2 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Meena 1 2 28 2 3 2 1 1 1 2 1510 1 1 2 1 1 1 4 1 1 1 3 1 3 1 4 2 1 1 1 1 2 1 8 8 8 2 3 3 2 3 3 2 2 
Meena2 2 28 2 3 2 1 1 2 2 1235 1 1 2 1 1 1 4 1 1 1 3 1 3 1 4 2 1 1 1 1 2 1 8 8 5 2 1 3 2 3 3 2 2 
Latha 4 34 1 3 1 2 2 2 2 1700 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 3 2 2 
Deepa 5 33 1 3 1 1 1 2 2 1965 1 3 1 2 3 1 1 1 2 2 1 1 1 1 2 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Chinna 
nagamma 
5 34 3 3 1 1 1 1 2 2095 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Muruganandhi 
1 
6 30 3 4 2 2 1 2 2 1415 1 2 2 1 1 4 1 1 1 1 4 3 3 1 4 2 1 1 1 1 1 2 5 5 5 1 1 3 2 3 3 2 2 
Jothi 5 30 4 4 2 1 1 2 2 1150 2 1 1 1 1 4 4 1 3 2 3 3 1 1 4 2 1 1 2 1 2 1 8 8 5 1 2 3 2 3 3 2 2 
Anitha 5 32 2 3 2 3 1 1 2 1550 1 3 1 1 3 2 4 1 1 1 1 1 3 4 3 2 1 1 1 1 1 2 8 5 7 1 2 3 2 3 3 2 2 
Jeyalakshmi 5 28 3 3 2 1 1 2 2 1060 3 1 1 1 1 4 4 1 2 2 3 1 1 1 4 2 1 1 1 1 1 2 7 7 7 1 1 3 2 3 4 2 2 
Gomathi 4 34 4 3 1 2 2 1 1 1500 3 2 1 2 1 4 2 1 2 2 3 1 3 4 4 2 1 1 1 2 4 2 7 7 7 1 1 3 2 3 3 2 2 
Ilamathi 2 5 33 2 4 2 1 1 2 2 2040 2 3 4 1 3 1 4 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 2 3 3 3 3 4 2 2 
Ilamathi 1/3 5 33 2 4 2 1 1 2 2 1715 1 3 4 1 3 1 4 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 3 2 2 
Saritha 4 30 1 3 1 2 1 2 2 1430 1 2 1 1 1 1 2 1 1 1 4 3 3 1 4 2 1 1 2 1 1 2 7 7 7 1 1 3 2 3 3 2 2 
Grace 3 29 4 3 2 3 1 1 2 1505 1 1 1 2 1 1 5 1 1 1 3 1 1 1 4 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 2 2 2 
Rani 2 28 2 3 2 1 1 2 2 1100 1 3 1 1 3 1 2 1 2 2 3 1 1 1 4 2 1 1 1 1 1 1 8 8 8 2 3 3 2 3 3 2 2 
Deepa 1 4 34 2 2 1 1 1 1 2 1970 1 1 3 1 1 1 4 1 2 2 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 3 3 4 3 2 2 2 
Saraswathi 5 34 3 3 1 1 2 1 1 1580 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 3 2 2 
Vanaja 4 33 4 3 2 2 1 1 2 1900 1 2 1 1 1 1 2 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 1 2 2 
Kanagavalli 5 30 3 3 2 1 2 2 2 1045 2 3 1 1 3 2 2 1 2 2 2 1 1 1 4 2 1 1 1 1 1 1 8 8 2 1 2 3 2 3 4 2 2 
Kavitha 3 5 34 1 4 2 2 2 1 1 1895 1 2 4 1 1 1 5 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 3 2 2 
Kavitha 2 5 34 1 4 2 2 2 1 1 1400 1 2 4 1 1 1 5 1 1 1 1 1 1 5 4 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 3 2 2 
Selvi 5 30 1 3 2 1 1 1 2 1570 1 1 1 1 1 4 4 1 1 1 3 1 3 1 4 2 1 1 1 2 1 2 2 2 7 1 2 3 4 3 3 2 2 
Rakhi 3 34 1 3 2 2 1 1 2 1960 1 2 1 1 1 4 4 1 1 1 1 1 1 1 2 2 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Valliammal 1 2 33 1 1 2 1 1 2 2 1500 1 1 2 1 1 1 5 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Valliammal 2 2 33 1 1 2 1 2 2 1 1090 1 1 2 1 1 1 5 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 2 3 3 4 3 2 2 2 
Malini 5 34 1 4 2 1 2 1 1 1645 1 3 1 1 1 3 4 1 1 1 2 1 3 4 4 2 1 1 1 2 2 1 7 7 7 1 1 3 3 3 3 2 2 
Ishwarya 5 34 1 3 2 1 2 1 1 1630 1 3 1 1 3 2 2 1 1 1 2 1 1 5 4 1 1 1 1 1 1 1 8 8 2 2 3 3 3 3 2 2 2 
Divya 2 32 1 2 2 1 2 2 1 1000 1 3 1 1 2 2 3 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 3 2 2 
Uma 
Maheswari 1 
5 33 4 2 1 2 1 2 2 1775 1 2 2 1 1 1 1 1 1 1 1 1 1 1 4 2 1 1 1 1 1 1 8 8 7 1 2 3 3 3 3 2 2 
Banupriya 6 34 4 1 1 1 2 1 1 1455 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 4 2 2 
Vennila 2 31 3 2 1 1 1 2 2 1935 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 4 3 2 2 2 
Jaya 5 31 3 3 1 2 2 2 1 1135 1 2 1 1 1 1 2 1 1 1 1 3 1 1 4 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 2 2 2 
Durga 5 32 1 3 1 1 1 2 2 1805 1 1 1 1 1 1 2 1 1 1 1 1 1 1 4 1 1 1 1 1 1 1 8 8 8 3 3 3 4 3 2 2 2 
Kavitha 2 33 1 3 2 2 2 2 1 1605 1 2 1 1 1 1 2 1 2 2 1 1 2 1 4 1 1 1 1 1 1 1 8 8 8 2 3 3 3 3 3 2 2 
Indra 1 5 31 1 3 2 2 1 1 2 1220 2 2 2 1 1 4 4 1 2 2 3 1 1 1 2 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 3 2 2 
Indra 2 5 31 1 3 2 2 1 1 1 1060 1 2 2 1 1 4 4 1 1 1 3 1 1 1 3 2 1 1 1 1 1 1 8 8 2 2 3 3 3 3 3 2 2 
Anu 4 32 1 3 2 1 1 1 2 1780 1 1 1 1 1 1 1 1 1 1 1 1 1 1 4 1 1 1 1 1 1 1 8 8 8 3 3 3 4 3 2 2 2 
Jeya 5 32 3 3 2 1 1 2 2 1860 1 1 1 1 1 1 2 1 1 1 2 1 1 1 3 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Valarmathy 2 33 1 4 2 1 1 2 2 1815 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 1 2 2 
Parveen 1 5 31 1 3 2 2 1 2 2 1545 1 2 2 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 2 2 2 3 3 3 4 2 2 
Banupriya 6 34 1 2 1 2 2 1 1 1455 1 2 1 1 1 1 2 1 1 1 1 1 1 1 4 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 3 2 2 
Parameswari 4 33 3 3 2 1 1 1 2 2470 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Malini 4 32 3 3 1 1 1 1 2 1780 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 4 3 2 2 2 
Sai Vishnu 
Priya 
2 30 4 4 1 1 1 1 2 1290 1 1 1 4 1 1 2 1 1 1 2 1 1 1 2 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 3 2 2 
Prasanna 5 34 2 3 2 1 2 2 1 1455 1 3 1 1 3 2 4 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 2 3 3 3 4 2 2 
Kalaivani 5 34 2 3 2 1 1 2 3 2850 1 1 1 1 1 1 1 1 1 1 1 1 1 1 4 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 1 2 2 
Mahalakshmi 5 31 1 2 1 2 1 2 2 1260 1 2 1 1 1 1 4 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Anitha 1 2 31 2 3 2 1 1 2 2 1530 1 1 3 1 1 1 2 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 2 2 2 
Anitha 2 2 31 2 3 2 1 1 2 2 1715 1 1 3 1 1 1 2 1 1 2 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 2 2 2 
Sasikala 5 33 4 3 2 1 2 1 2 1885 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Durga 5 32 1 3 2 1 2 2 1 1195 1 3 1 1 2 4 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Vaitheeswari 4 29 1 3 2 1 2 1 2 1380 1 1 1 4 1 1 4 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 2 2 3 3 3 3 2 2 
Palpandi 1 5 30 1 3 1 1 1 1 2 1500 1 1 3 1 1 1 2 1 2 2 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 2 2 2 
Palpandi 2 5 30 1 3 1 1 1 1 2 1385 1 1 3 1 1 1 2 1 2 2 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 2 2 3 3 3 2 2 2 
Bharathi 1 2 28 1 3 2 2 1 2 2 930 1 2 4 1 1 1 4 1 1 1 4 1 3 1 4 2 3 2 1 2 3 2 7 7 7 1 1 3 2 3 2 2 2 
Bharathi 2 2 28 1 3 2 2 1 2 2 980 1 2 4 1 1 1 4 1 1 1 1 1 1 1 4 2 1 1 1 1 1 1 8 8 8 3 3 3 3 3 1 2 2 
Bharathi 3 2 28 1 3 2 2 1 2 2 895 1 2 4 1 1 1 4 1 1 1 3 1 1 1 4 2 1 1 1 1 1 1 8 8 8 2 2 3 2 3 2 2 2 
Anitha 1 2 31 1 3 2 2 1 1 2 1490 1 2 2 1 1 1 2 1 1 1 1 1 1 1 4 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 1 2 2 
Pattu 1 4 29 4 3 2 1 1 2 2 1145 1 1 2 4 1 1 2 1 1 1 1 1 1 1 4 2 1 1 1 1 1 1 8 8 8 2 3 3 3 3 2 2 2 
Pattu 2 4 29 4 3 2 1 1 1 2 1135 2 1 2 4 1 1 2 1 1 1 2 1 1 1 4 2 1 1 1 1 1 1 8 2 2 1 2 3 2 3 3 2 2 
Nirosha 4 33 1 3 2 2 1 2 2 1870 1 2 1 1 1 1 2 1 1 1 1 1 1 1 4 1 1 1 1 1 1 1 8 8 8 3 3 3 4 3 2 2 2 
Jansi rani 3 33 3 3 2 2 1 2 2 2000 1 2 1 1 1 1 4 1 1 1 1 1 1 1 3 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 1 2 2 
Sumathy 6 30 1 2 1 4 1 1 3 2210 1 1 1 1 1 1 2 1 1 1 1 1 1 1 3 1 1 1 1 1 1 1 8 8 8 2 3 3 3 3 1 2 2 
Selvakumari 3 32 4 4 2 2 1 1 2 1530 1 2 1 1 1 1 1 1 1 1 1 1 1 1 4 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 2 2 2 
Elamozhi 5 32 2 3 1 1 1 2 2 1475 1 1 1 1 1 1 2 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 8 8 8 3 3 3 4 3 1 2 2 
Nirmala 3 33 1 3 2 3 1 1 2 2105 1 1 1 1 1 1 2 1 2 2 1 1 2 1 4 2 1 1 1 1 2 1 8 7 7 1 1 3 3 3 3 2 2 
Vasanthakumari 5 34 1 3 1 2 1 1 2 1925 1 2 1 1 1 1 2 1 2 2 1 1 1 1 4 1 1 1 1 1 1 1 8 8 8 3 3 3 3 3 3 2 2 
Vijayashanthi 3 34 4 3 2 1 1 1 3 3195 1 1 1 1 1 1 4 1 2 2 3 1 1 1 3 2 1 1 1 1 1 1 5 5 7 1 1 2 3 3 1 2 2 
Anitha 2 2 32 1 4 2 1 2 1 1 1140 1 1 3 1 1 4 2 1 1 1 3 1 3 1 4 2 2 1 1 1 2 1 8 8 1 2 2 3 3 3 3 2 2 
Malliga 5 28 3 2 1 1 1 1 2 1000 1 1 1 1 1 1 2 1 1 1 3 3 1 1 4 2 1 1 1 1 1 1 8 4 7 1 2 3 2 3 3 2 2 
Revathy 1 5 31 1 3 2 1 2 2 1 1250 1 3 3 1 1 2 4 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8 8 8 3 2 3 3 3 2 2 2 
Malini 4 34 1 3 2 1 2 1 1 1655 1 3 1 2 1 2 2 1 1 1 3 1 3 4 4 2 1 1 1 2 3 2 7      2   2 3 
Nandhini 1 2 33 1 3 2 2 1 2 2 1795 1 2 2 1 1 1 2 1 1 1 1 1 1 1 3 2 1 1 1 1 1 1 8      3   2 3 
Haripriya 1 5 34 1 3 1 1 2 2 1 1650 1 3 1 1 2 4 1 1 1 1 1 1 1 4 2 2 1 1 1 1 1 1 8      3   2 3 
Gowri 6 33 1 3 1 2 1 2 2 2010 1 2 1 1 1 1 2 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 8      3   2 3 
Lakshmi priya 1 2 34 1 3 1 1 2 1 2 1915 1 1 2 1 1 4 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8      3   2 3 
Lakshmi priya 2 2 34 1 3 1 1 2 2 1 1685 1 1 2 1 1 4 2 1 2 2 2 1 1 1 1 2 1 1 1 1 1 1 8      3   2 3 
Sridevi 2 32 4 3 1 1 2 1 1 1300 1 3 1 2 1 4 1 1 2 4 4 1 3 5 4 2 1 1 1 1 2 2 8      3   2 3 
Chitramani 2 29 1 4 2 1 1 2 2 1170 1 1 1 1 1 1 2 1 1 1 3 1 1 1 4 2 1 1 2 1 1 1 8      2   2 3 
Elakkiya 5 30 4 3 2 1 1 1 2 1670 1 1 1 4 1 1 1 1 2 2 4 3 1 1 3 2 1 1 2 1 2 2 8      2   2 3 
Chitra 2 31 2 3 2 1 1 1 2 1640 1 1 1 1 2 2 5 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8      3   2 3 
Pushpalatha 2 33 1 4 2 1 2 1 1 1135 1 3 1 1 1 3 2 1 1 1 2 1 3 1 4 2 1 1 1 1 1 1 8      2   2 3 
Dhatchayani 5 32 1 3 1 2 1 2 2 1630 1 2 1 1 1 1 2 1 1 1 1 1 1 1 4 2 1 1 1 1 1 1 8      3   2 3 
Parveen 2 5 31 1 3 2 1 1 2 2 1265 1 2 2 2 1 4 2 1 2 2 3 1 1 1 4 2 1 1 1 1 3 2 7      2   2 3 
Kanmani 5 31 1 3 2 2 1 1 2 1875 1 2 1 1 1 1 2 1 2 2 1 1 1 1 1 2 1 1 1 1 1 1 8      3   2 3 
Dharani 5 33 1 3 2 2 1 1 2 1850 1 2 1 1 1 1 2 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 8      3   2 3 
Bhavani 2 31 1 3 2 1 2 1 1 935 1 3 1 1 2 3 5 1 1 1 1 1 1 1 3 2 1 1 1 1 1 1 8      3   2 3 
Vijayalakshmi 
1 
4 32 1 3 1 1 2 1 1 1360 1 1 3 1 1 1 2 1 1 1 1 1 1 1 4 1 1 1 1 1 1 1 8      3   2 3 
Ashwini 2 34 3 3 2 1 2 2 1 1375 1 3 1 1 3 2 4 1 1 1 1 1 3 1 2 2 1 1 1 1 1 1 8      3   2 3 
Priya 5 33 1 4 2 1 2 2 1 1110 2 3 1 2 3 4 1 2 4 4 3 1 3 1 4 2 1 1 1 1 1 2 2          3 
Sharadha 5 33 2 3 1 2 1 2 2 2010 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8      3   2 3 
Divya 2 29 3 2 2 1 2 2 2 810 1 3 1 1 1 3 4 1 1 1 3 1 3 1 4 2 1 1 1 1 2 1 8      3   2 3 
Bharathi 5 30 3 3 1 1 1 2 2 1340 1 1 1 1 1 1 3 1 1 1 3 1 1 1 4 2 1 1 1 1 1 1 8      3   2 3 
Jothi 5 30 1 3 1 2 1 2 2 1140 1 2 1 3 1 1 2 1 3 4 4 1 3 1 4 2 1 1 1 2 1 2 5      2   2 3 
Logapriya 5 32 3 3 1 2 1 2 2 1535 1 2 1 1 1 1 2 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 8      3   2 3 
Kamala 1 33 2 3 2 2 1 1 2 2395 1 2 1 1 1 2 2 1 1 1 2 1 1 1 3 2 1 1 1 1 1 1 8      3   2 3 
Mohanaselvi 4 28 1 3 2 2 1 1 2 1030 1 2 1 1 1 1 2 1 1 1 3 1 1 1 4 2 1 1 1 1 2 1 8      2   2 3 
Priya 5 28 1 2 2 3 1 2 2 1190 1 1 1 1 1 1 1 1 2 2 3 1 3 1 4 2 1 1 1 1 1 2 2      2   2 3 
Mahalakshmi 1 2 32 1 3 2 2 1 2 2 1770 1 2 2 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 8      4   2 3 
Mahalakshmi 2 2 32 1 3 2 2 1 1 2 1895 1 2 2 1 1 1 2 1 1 1 4 1 3 1 4 2 1 1 1 1 3 2 7      3   2 3 
 
 
 
